Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
WAKE FOREST UNIVERSITY HEALTH SCIENCES CLINICAL CARDIOLOGY / CLINICAL CARDIOVASCULAR RESEARCH TRAINING PROGRAM CURRICULUM VITAE Director T32 Program: David M. Herrington, MD, MHS Associate Director T32 Program: Elsayed Soliman, MD, MSc , MS Wake Forest University Health Sciences Department Of Internal Medicine / Section on Cardiology Medical Center Blvd. Winston-Salem, NC 27157 [email protected] 336-716-4950 [email protected] 336-716-8632 Sponsor: NIH/NHLBI T32 CVD Epidemiology Training Program OBJECTIVE: The purpose of the CVD Epidemiology Training Program, a federally-funded National Research Service Award (NRSA) Institutional Research Training Grant (2 T32 HL076132), is to attract and train a cohort of outstanding physician scientists who will be fluent in the latest developments in cardiovascular disease and able to apply this knowledge to the conduct of new cardiovascular epidemiology and clinical cardiovascular research. Key features of the training program include completion of a Masters Degree in Clinical and Population Translational Science with a curriculum that also includes formal training in molecular biology and genetics, supplemental training in genomics, proteomics and informatics, joint mentorship with both clinical and basic science faculty, and participation in external NHLBI sponsored short courses in cardiovascular epidemiology, and the genetics of complex heart, lung, and blood disorders. CURRENT TRAINEES: 1. Dr. Mohamed Faher Almahmoud – appointed 7/1/2015 Current: MS, Clinical and Population Translational Science, Wake Forest University MD, University of Aleppo, Syria, 2010 MS, Clinical and Population Translational Science, Wake Forest University, 2016 Thesis: Serum Fibroblast Growth Factor-23 and Cardiac Magnetic Resonance Indices of Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis 2. Dr. Abdullahi Oshioke Oseni – appointed 7/1/2015 Current: MS, Clinical and Population Translational Science, Wake Forest University MBBS, University of Ilorin College of Medicine, Nigeria 3. Dr. Adam Leigh – appointed 7/1/2015 Current: MS, Clinical and Population Translational Science, Wake Forest University MD, Wake Forest University, Winston-Salem, NC, 2012 PAST TRAINEES: 1. Dr. Shivani Aggarwal – appointed 7/1/2013- 6/30/2015 Current: Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2014 MS, Clinical and Population Translational Science, Wake Forest University, 2015 Thesis: Parity and Cardiovascular Disease MBBS, Adichunchanagiri Institute of Medical Sciences, India, 2007 2. Dr. Waqas Qureshi – appointed 7/1/2013 – 6/30/2015 Current: Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2014 MS, Clinical and Population Translational Science, Wake Forest University, 2015 Thesis: Metabolomic Signature of Hypertension MBBS, Rawalpindi Medical College, Pakistan, 2007 3. Dr. Michael Cammarata – appointed 7/1/2012-6/30/2014 Current: Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2013 MS, Clinical and Population Translational Science, Wake Forest University, 2015 Thesis: DNA Methylation and Gene Expression of P2RY12 in a Multi-Ethnic Cohort MD, University of Florida College of Medicine, 2008 4. Dr. Ashleigh Owen – appointed 7/1/2012-6/30/3014 Current: Wake Forest University, MS, Clinical and Population Translational Science Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2013 MD, Medical University of South Carolina College of Medicine, 2009 5. Dr. Robert Riley – appointed 7/1/2011-6/30/2013 Current: Electrophysiology Fellow, University of Washington, Seattle, Washington Clinical Cardiology Fellow, Internal Medicine/ Cardiology, Wake Forest University, 2012-2015 MS, Clinical and Population Translational Science, Wake Forest University, 2013 Thesis: The Development and Implementation of Secondary Prevention Measures for Coronary Artery Disease MD, University of Virginia, 2008 6. Dr. Farah Dawood - appointed 7/1/2011-6/30-2013 Current: Assistant Professor, Internal Medicine/Cardiology, Wake Forest University Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2012-2015 MS, Clinical and Population Translational Science, Wake Forest University, 2015 Thesis: High Sensitivity C-Reactive Protein And Risk Of Stroke In Atrial Fibrillation: The Reasons For Geographic And Racial Differenced In Stroke (Regards) Study MD, Virginia Commonwealth University, 2008 7. Dr. Amir Azeem – appointed 7/1/2011-6/30/2013 Current: Electrophysiology Fellow, Internal Medicine/Cardiology, Wake Forest University Clinical Cardiology Fellow, University of Mississippi, Jackson, MS 2013-2015 MS, Clinical and Population Translational Science, Wake Forest University, 2013 Thesis: Hemoglobin A1C and Prediction of Cardiovascular Disease and All-Cause Mortality MBBS, Dow Medical College, Karachi, Pakistan, 1999 8. Dr. Matthew Sellers – appointed 7/1/2010-6/30/2012 Current: Cardiologist, Anmed Health Arrhythmia Specialists, Anderson, SC Electrophysiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2014-2015 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2011-2014 MS, Clinical and Population Translational Science, Wake Forest University, 2013 Thesis: Replication and Functional Validation of SNPs Previously Associated with Coronary Artery Disease. MD, Medical University of South Carolina College of Medicine, 2007. 9. Dr. Pelbreton Balfour – appointed 7/1/2010-6/30-2012 Current: Fellow, Advance Cardiac Imaging Fellowship, University of Virginia, Charlottesville, VA Research Assistant, Division of Public Health Sciences, Wake Forest University, 2014-2015 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2011-2014 MS, Clinical and Population Translational Science, Wake Forest University, 2014 Thesis: Amino-Terminal Pro-Brain Natriuretic Peptide, Diabetes, And Incident Heart Failure: The Multi-Ethnic Study Of Atherosclerosis MD, University of Pittsburgh School of Medicine, 2006. 10. Dr. Jennifer Anderson – appointed 7/1/2009-6/30-2011 Current: Cardiologist, St. Alphonsus Medical Center, Boise Idaho Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2010-13 MD, University of Washington – Seattle, Washington, 2006. PhD, University of Washington – Seattle, Washington, 2002. MS, Clinical and Populational Translational Science, Wake Forest University, 2011 Thesis: Sex Differences in the relationship of Polyunsaturated Fatty Acids and Noninvasive Imaging Measure of Subclinical Cardiovascular Disease. 11. Dr. Subhashish Agarwal – appointed 7/1/2009-6/30/2011 Current: Director, Cardiovascular Services, Prairie Heart Institute, Effingham, IL Electrophysiology Fellow, Oakwood Hospital & Medical Center Cardiology Fellowship Program, Dearborn, MI, 2014-2015 Clinical Cardiology Fellow, Oakwood Hospital & Medical Center Cardiology Fellowship Program, Dearborn, MI, 2011-2014 MS, Clinical and Populational Translational Science, Wake Forest University, 2011 Thesis: Metabolic Syndrome derived from Principal Component Analysis and Predication of Incident Cardiovascular Events Multi Ethnic Study of Atherosclerosis (MESA) MBBS, University of Mumbai, Mumbai, India, 1997. 12. Dr. Peter Matthew Belford – appointed 7/1/2008-6/30/2010 Current: Assistant Professor, Internal Medicine/Cardiology, Wake Forest University, 2014 Cardiologist, Morehead Hospital, Eden, NC, 2012 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2009-2012 MD, Wake Forest University, 2004. 13. Dr. Manish Jain – appointed 7/1/2008-6/30/2010 Current: Cardiologist/Electrophysiologist, South Carolina Heart Center, Columbia, SC Electrophysiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2012 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2009-2012 MS, Clinical & Population Translational Science, Wake Forest University, 2011 Thesis: Association of Visceral Adipose Tissue (VAT) with Pulse Pressure (PP) in the Multi Ethnic Study of Atherosclerosis. MD, University of Texas-South Western, 2004. 14. Dr. Sidharth Shah – appointed 7/1/2007-6/30/2009 Current: Cardiologist, Wake Heart and Vascular, Raleigh, NC Electrophysiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2012 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2008-2011 MS-Wake Forest University, MS, Health Services Research, 2010 Thesis: Genetic Variants in NOS1AP and the QT Interval MD, University of Kansas – Kansas City, 2004. 15. Dr. Brandon Stacey – appointed 7/1/2007-6/30/2009 Current: Assistant Professor, Internal Medicine/Cardiology, Wake Forest University Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2008-2011 MS- Wake Forest University, MS, Health Services Research, 2009 Thesis: Modification of the Effect of Glycemic Status on Aortic Distensibility by Age in the Multi-Ethnic Study of Atherosclerosis MD, University of South Alabama College of Medicine – Mobile, 2004. 16.Dr. Stewart Allen– appointed 7/1/2006-6/30/2008 Current: Cardiologist, St. Helena Cardiology, St. Helena, CA Interventional Fellow, Internal Medicine/Cardiology, Wake Forest University, 2011 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2007-2010 MS-Wake Forest University, MS, Health Services Research, 2009 Thesis: The Association of Selective and Nonselective Nonsteroidal Antiinflammatory Medications with Reverse Endothelial Function and Indices of Thrombosis in the Multi-Ethnic Study Of Atherosclerosis MD, Wake Forest University, 2001. 17. Dr. Darryl Prime– appointed 7/1/2006-6/30/2007 Current: Cardiologist, Gadsden Regional Medical Center, Gadsden, AL Interventional Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2010-2011 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2007-2010 MS- Health Services Research, Wake Forest University, 2008 Thesis: The Utility of Pulse Pressure Measured by Radial Arterial Tonometry in Determining Cardiovascular Disease in Adults MD, University of Alabama - Birmingham, 2002. 18. Dr. Kurt Daniel – appointed 7/1/2005 – 6/30/2007 Current: Cardiologist, Carolina Cardiology Associates, High Point, NC Interventional Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2009 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2006-2009 MS-Health Services Research, Wake Forest University, 2007 Thesis: Genetic Variations in the ATP-Binding Cassette Gene are Associated with Altered Levels of Markers of Systemic Inflammation DO, Oklahoma State University, 2001. 19. Dr. Jerry John– appointed 7/1/2005 – 6/30/2007 Current: Co-Director, Heart Failure Prevention and Treatment Program, McKay-Dee Hospital Center / Intermountain Health Care, Ogden, UT Fellow, Clinical Cardiology, University of Toledo Medical Center, 2007-2010 Wake Forest University, MS, Health Services Research, 2007 Thesis: Response to Postural Change in Diastolic Heart Failure: Decreased Left Thesis: Ventricular Compliance Contributes to Reductions in Stroke Volume and Cardiac Output MD, Michigan State University, 2001. 20. Dr. Joseph Yeboah– appointed 7/1/2005 – 6/30/2007 Current: Assistant Professor, Internal Medicine, Section on Cardiology, Wake Forest University, 2011 Fellow, Clinical Cardiology, University of Virginia, 2008-2011 Fellow, Critical Care, Wake Forest University, 2007-2008 Wake Forest University, MS, Health Services Research, 2007 Thesis: Predictive Value of Endothelial Dysfunction for Incident Cardiovascular Events in the CHS Cohort MD, Yale University, 2005. 21. Dr. Phillip Mellen - appointed 7/1/2004 – 6/30/2006 Current: Internist, Hattiesburg Clinic’s Hypertension Center of Excellence Assistant Professor, Internal Medicine, Wake Forest University, 2006-2007 MS-Health Services Research, Wake Forest University, 2006 Thesis: Whole Grain Intake and Progression of Carotid Atherosclerosis in a Multi-Ethnic Cohort: The Insulin Resistance Atherosclerosis Study MD – University of Mississippi, 2001. 22. Dr. Susan Lakoski – appointed 7/1/2004 – 6/30/2005 Current: Associate Professor, Department of Clinical Cancer Prevention and Department of Cardiology, The University of Texas MD Anderson Cancer Center, 2015 Assistant Professor of Medicine. University of Vermont College of Medicine, 2013-2015 Assistant Professor Cardiology, University of Texas, 2008-2013 Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University, 2005-2008 MS-Health Services Research, Wake Forest University, 2005 Thesis: The Relationship Between Blood Pressure and C-Reactive Protein in the Multi-Ethnic Study of Atherosclerosis (MESA) MD – University of Texas, 2000. EDUCATIONAL REQUIREMENTS OF THE CVD EPIDEMIOLOGY TRAINING PROGRAM: Masters Degree Clinical and Population Translational Sciences, Wake Forest University AHA’s 10 day Seminar on the Epidemiology and Prevention of Cardiovascular Disease AHA’s Annual Conference on Cardiovasular Disease Epidemiology and Prevention in Association w/the Council on Nutrition, Physical Activity and Metabolism. Faculty Development Program Ethics in Science course offered through Grad school The Collaborative IRB Training Initiative (CITI) The Human Research Subject Protection Certification Program and HIPPA Compliance training courses. NIH online course on responsible conduct of research. AWARDS AND HONORS: Dr. Susan Lakoski, NIH Loan Repayment Award, 2004. Dr. Kurt Daniel, NIH Loan Repayment Award, 2005. Dr. Susan Lakoski, Sandra Daugherty Award for Excellence in Cardiovascular Disease and Hypertension Epidemiology. 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, April 2005. Dr. Kurt Daniel, Travel award from GSK Research & Education Foundation for CVD to attend the New Frontiers in Genomics and Cardiovascular Disease Conference in Philadelphia, April 2005. Dr. Kurt Daniel, Henry I Russek Travel Award to attend the 37th Annual Cardiovascular Symposium from the American College of Cardiology, December 2005. Dr. Darryl Prime, Travel Award to attend the AHA’s 43th 10-Day Seminar on the Epidemiology and Prevention of Cardiovascular Disease, 2008 Dr. Susan Lakoski, Women in Cardiology Trainee Award for Excellence , American Heart Association’s Scientific Sessions 2006, November 12- November 15, 2006. Dr. R. Brandon Stacey, NIH Loan Repayment Award, 2007 Dr. Stewart Allen, American Heart Association Spotlight Series Speaker, 2007 Dr. Jerry John, First Place – Oral Abstract Presentation , The Determinants of Exercise Intolerance in Diastolic Heart Failure Patients, Ohio Chapter American College of Cardiology, 2007 Dr. P. Matthew Belford, NIH Loan Repayment Award, 2008 Dr. P. Matthew Belford, Travel Award to attend the AHA’s 43th 10-Day Seminar on the Epidemiology and Prevention of Cardiovascular Disease, 2008 Dr. Joseph Yeboah, Finalist, Elizabeth Barrett-Connor Research Award for Young Investigators in Training, 2008 Dr. Sidharth Shah, Fellow Basic Research Silver Award Third Annual Internal Medicine Resident and Fellow Research Day April 2009. Poster presentation of: Shah SA, Herrington DM, Howard TD, Burke GL, Kao WH, Guo X, Siscovick DS, Chakravarti A, Lima JA, Psaty BM, Tomaselli GF, Rich SS, Bowden DW, and Post W. Associations Between Genetic Variations in NOSIAP and QT Interval Duration in Four Racial/Ethnic Groups in the Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Sidharth Shah, A.M. Nomeir Award for Excellence in Echocardiography, July 2009. Dr. Sidharth Shah, Note of Appreciation, 3rd year Medical Students of Wake Forest University School of Medicine- Internal Medicine Rotation. December 2010. Dr. Jennifer Anderson, Finalist, Elizabeth Barrett-Connor Research Award for Young Investigators in Training, 2010 Dr. Susan Lakoski, Endocrine Society International Award for Excellence in Published Clinical Research, 2012 Dr. Robert Riley, First Place Award (Gold Award), Wake Forest University School of Medicine Resident/Fellows Research Day, “Guideline-Based Treatment of Anemic STEMI Patients: A Report from the ACTION Registry® - GWTGTM”, May 8, 2012. Dr. Pelbreton Balfour, Second Place Award, Wake Forest University School of Medicine Resident/Fellows Research Day,” The Association between Amino Terminal Pro-Brain Natriuretic Peptide and Incident Heart Failure in Diabetes- The Multi Ethnic Study of Atherosclerosis”, May 8, 2012. Dr. Susan Lakoski, International Award for Excellence in Published Clinical Research, Endocrine Society, Journal of Clinical Endocrinology and Metabolism, 2012. Dr. Amir Azeem, Fellow of American College of Physicians (FACP), Sept 2012. Dr. Robert Riley, First Place Award (Gold Award), Wake Forest University School of Medicine Resident/Fellows Research Day, 2013 Dr. Pelbreton Balfour, Clinical Cardiology Minority Travel Grant Award, 2013 AHA Scientific Sessions. Dr. Joesph Yeboah, NHLBI-MESA Young Investigator Award 2013. Dr. Waqas Qureshi, Reviewer, Annals of Internal Medicine 2013. Dr. Pelbreton Balfour, Second Place Award, Wake Forest School of Medicine Eighth Annual Research Day, “Clinical Determinants of Global Left Ventricular Systolic Function by Cardiac Magnetic Resonance Imaging: The Jackson Heart Study”, May 2014. Dr. Waqas Quershi, AHA Top 10% Abstracts , “Metabolomic Features Associated With Incident Hypertension - Results From Insulin Resistance Atherosclerosis Study,” Best of AHA Speciality Conference AHA Scientific Sessions, Nov 2014. Dr. Joseph Yeboah, Harold Amos Faculty Development Award Competition Finalist, 2014 Dr. Robert Riley, First Place Award (Gold Award), Wake Forest University School of Medicine Resident/Fellows Research Day, 2014 Dr. Brandon Stacey, Excellence in Teaching Recognition, Internal Medicine Residency Program, Wake Forest University School of Medicine, 2014 Dr. Brandon Stacey, Tinsley Harrison Research Scholar Mentor Award, 2014 Dr. Brandon Stacey, Cardiovascular Medicine Outstanding Teaching Award for Non-Invasive CV Medicine, August 2014. Dr. Jerry John, Gold Achievement Award - AHA 2014. Dr. Jerry John, Mckay-Dee Award for 3rd Lowest Heart Failure Readmission Rate in Country – CMS, 2014. Dr. Pelbreton Balfour – Finalist, The Dr. Jay Brown Best Abstract Competition, Association of Black Cardiologists, 2014. Dr. Pelbreton Balfour – Ruth L. Kirschstein National Research Service Award, NIBIB T32 EB003841, 2015. Dr. Waqas Qureshi – Clinical Cardiology Travel Award by the AHA, 2015. Dr. Waqas Qureshi – Young Investigator Award, European Society of Cardiology, 2015. GRANTS: Funded: Dr. Susan Lakoski, PI, The Association Between Interleukin-1 Receptor Associated Kinases (IRAK1) Genetic Variants and IL-10 levels in the ERA Study. Funded by the Wake Forest University Center for Public Health Genomics, June 2005. Dr. Philip Mellen, Co-I, “Dietary Fats, Genetic Variation, and Progression of Coronary Atherosclerosis Among Women” 2005. Dr. Philip Mellen, PI, “Serum Uric Acid and Incident Metabolic Syndrome in the Atherosclerosis Risk in Communities Cohort” 2004-2006 Dr. Philip Mellen, Co-I, “Effect of Muscadine Grapeseed Extract on Endothelial Function” (Natures Pearl, Inc.) 2006-2007. Dr. Susan Lakoski (PI) “Cardiorespiratory Fitness and Healthy Aging: The Cooper Reunion” The Cooper Institute – Foundation Grant ; Project Period: 7/1/2009-6/30/11 Dr. Jerry John (Co-I) “LAPTOP-HF (Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy) 2011-present. Dr. Joseph Yeboah, Robert M. Berne Cardiovascular Research Center Training Grant, University of Virginia (5T32-HL007284 / Dr. Brain Duling, Program Director ). July 2010 – June 2012. Dr. Joseph Yeboah (Co-I), “Longitudinal Changes in Pericardial Adiposity and Subclinical Atherosclerosis” R01 HL 098445 Project Period: 08/01/2010-03/31/2014 Dr. Brandon Stacey (Co-I), “Atherosclerosis Risk in Communities (ARIC) Study – Field Centers” HHSN268201100007C (Wagenknetcht); Project Period: 11/15/2010–1/14/2016. Dr. Matt Sellers and David Herrington. Epigenetic Analysis of Lipid Phenotypes in Liver Tissue from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study TSI Pilot Funding Program. 4-1-2011 to 3-31-2012. Dr. Joseph Yeboah (Co-I), “Preventing Anthracycline Cardiovascular Toxicity with Statins” R01HL118740-01; Project Period: 04/01/2013 – 03/31/2018 Dr. Joseph Yeboah (Co-I), “Multi-Ethnic Study of Atherosclerosis - Field Center” N01-HC-95165; Funding: Jan 2014-8/14/2015 Dr. Joseph Yeboah (Co-I), “Systolic Blood Pressure Intervention Trial (SPRINT)” HHSN268200900048C; Project Period: 09/14/09 – 09/13/18 Dr. Robert Riley,PI “Are serial electrocardiograms Additive to serial second-generations troponins in Predicting acute coronary Syndromes in patients with undifferentiated chest pain (ASAP CATH) Study” Wake Forest University Baptist Medical Center Initiative for Healthcare Delivery Innovation Project Application. Project Period: 7/1/13-6/30/14 Dr. Robert Riley,PI AHA/ MAA Winter 2013 Clinical Research Program “Are Serial ECGs Additive to Novel Serial Troponins in Predicting ACS in Patients with Undifferentiated Chest Pain Study”Project Period: 7/1/13-6/30/15 Dr. Susan Lakoski (PI) Centers of Biomedical Research Excellence (P20GM103644-01A1) Project 5 Title: “Behaviors, Chronic Disease, and Quality of Life After Ductal Carcinoma in Situ” Project Period: 8/1/13- 6/30/18 . Dr. Susan Lakoski (PI) REACH Institutional Grant Program – University of Vermont Title: “An Exercise Training and Behavior Weight Loss Program after an Acute Blood Clot: TRAIN ABC” Project Period: 6/1/2013-6/30/14 Dr. Susan Lakoski (PI) University of Vermont School of Medicine Title: “Exercise Training for the Prevention of Cancer Thrombosis: the EXPECT Pilot Trial” Project Period: 4/1/2012-6/30/15 Dr. Susan Lakoski (Co-I) University of Vermont School of Medicine Title: “Predictors of Dyspnea/Fatigue Syndrome in Breast Cancer Survivors Before and After an Exercise Intervention” Project Period: 7/12 - present Dr. Pelbreton Balfour, PI, Investigator Research Supplement (IRS) to the NHLBI for a supplement which promotes diversity in health-related research. The parent grant is Epidemiologic Determinant of Cardiac Structure and Function Among Hispanics (R01 HL104199; Carlos J. Rodriguez, PI). Project Period: 7/1/13-6/30/15 Dr. Brandon Stacey, Co-I, “Pre-Determine Study” Project Period: 2014-present. Dr. Amir Azeem, Co-I, “Association between Glycemic Status and Cardiac MRI Measures of Myocardial Structure and Function in African Americans – Jackson Heart Study” Project Period: 2014-present. Dr. Robert Riley, PI, “The PARA-Heart Study” (AKA: The Seattle Heart Study) Project Period 7/15-9/16. Currently pending review by Abbott Point-of-Care Investigator-Initiated Pilot Grant Committee. Dr. Amir Azeem, Co-I, “Impact of Obesity in Patients with Adult Congenital Heart Disease.” University of Mississippi Medical Center. Project Period: 10/15-Present. Dr. Joseph Yeboah, Co-I, “Early Imaging Detection of CV Injury After Cancer.” NIH R01 CA167821 (PI: Gregory Hundley). Project Period: 6/12-4/17. Dr. Joseph Yeboah, Co-I, “From Risk Factors to heart Failure: Prevelance, Pathogenesis and Phenomics MESA EXAM 6.” NHLBI: R01 HL 127028-0 (PI: Alain Bertoni). Project Period: 7/15-6/19. Dr. Farah Dawood, Co-I, “Inflammatory and Thrombosis Biomarkers and the Risk of Incident Stroke in Atrial Fibrillation: The Reasons for Geographic and Racial Differenced in Stroke (REGARDS) Study.” NINDS. 2015. Dr. Farah Dawood, Co-I, “Atrial fibrillation prevalence and clinical correlates among diverse Hispanic/Latinos: The Hispanic Community Health Study / Study of Latinos (HCHS-SOL).” NHLBI. 2015. Dr. Farah Dawood, Co-I, “The Efficacy and Safety of Transvenous Pacing: The Wake Forest University Experience.” WFU. 2015. Dr. Matthew Belford, PI, IRB study regarding radial artery occlusion in the heart catheterization lab. WFU. Project Period: 12/2015-Present Dr. Matthew Belford, PI, CardioMEMS Post Approval Study (Wake Forest site) St. Jude. Period: 8/2015-Present Project Dr. Matthew Belford, Site Specialty-Primary Investigator, “BEST-CLI : a Randomized, Multicenter, Controlled Trial to Compare Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia.” New England Research Institute. Project Period: 7/2015-Present Dr. Susan Lakoski, PI, “Research Initiation Funds (Lakoski), University of Texas M.D. Anderson Cancer Center.” Project Period: 9/2015-8/2017 Dr. Susan Lakoski, PI, “Cardiorespiratory Fitness and Healthy Aging: The Cooper Reunion.” The Cooper Institute Foundation. Project Period: 7/2009-6/201. Dr. Susan Lakoski, Co-I, “Cardiovascular Imaging and Strategies to Mitigate the Risk for Cardiac Events in Astronauts during Prolonged Spaceflight.” National Space Biomedical Research Institute. Project Period: 6/2010-3/2012. Dr. Joseph Yeboah, PI, Understanding the Effects of the Dominant Contemporary Breast Cancer Therapies on Atherosclerotic Cardiovascular Disease, 1R01CA207755-01. Dr. Waqas Qureshi, PI, “Identifying Metabolomic Signature of Mitochondrial Dysfunction in Heart Failure with Preserved Ejection Fraction Patients – A Pilot Study,” Wake Forest University Clinical and Translational Science Institute Ignition Fund Pilot Award. Project Period: 3/2016-5/2016 BIBLIOGRAPHY: Journal Articles 1. Bonds DE, Palla S, Bertoni AG, Mellen P, Goff DC. Hypertension treatment in the ambulatory setting: comparison by race and gender in a national survey. J Clin Hypertens (Greenwich). 2004;6(5):223-8; quiz 9-30. 2. Herrington DM, Lakoski SG. Chest Pain in Postmenopausal Women on Hormone Therapy. American College of Cardiology Foundation and Elseiver, Inc.; 2004 [updated 2004; cited]; Cardiosource Web Site]. Available from. 3. Mellen PB, Palla SL, Goff DC, Jr., Bonds DE. Prevalence of nutrition and exercise counseling for patients with hypertension. United States, 1999 to 2000. J Gen Intern Med. 2004;19(9):917-24. PMCID: 1492516. 4. Lakoski SG, Brosnihan B, Herrington DM. Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial. Am Heart J. 2005;150(5):907-11. 5. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB, Jr., Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2005;46(10):1869-74. 6. Lakoski SG, Herrington DM. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article. Climacteric. 2005;8(4):317-26. 7. Lakoski SG, Herrington DM. Effects of oestrogen receptor-active compounds on lipid metabolism. Diabetes Obes Metab. 2005;7(5):471-7. 8. Mellen PB, Herrington DM. Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens. 2005;23(7):1311-25. 9. John JM, Herrington DM. Maintenance warfarin dose varies according to two haplotypes of the vitamin K epoxide reductase gene. Future Cardiol. 2006;2(1):29-32. 10. Lakoski S, Herrington D, Siscovick D, Hulley S. C-reactive protein is an intermediate step between obesity and hypertension-Reply. Arch Intern Med 166 (1527)2006. 11. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB, Jr., Herrington DM. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. 2006;152(3):593-8. 12. Lakoski SG, Herrington DM, Siscovick DM, Hulley SB. C-reactive protein concentration and incident hypertension in young adults: the CARDIA study. Arch Intern Med. 2006;166(3):345-9. 13. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, Wofford MR, Herrington DM. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension. 2006;48(6):1037-42. 14. Mellen PB, Cefalu WT, Herrington DM. Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women. Arterioscler Thromb Vasc Biol. 2006;26(1):189-93. 15. Kitzman DW, Daniel KR. Diastolic heart failure in the elderly. Heart Fail Clin. 2007;3(4):437-53. 16. Kitzman DW, Daniel KR. Diastolic heart failure in the elderly. Clin Geriatr Med. 2007;23(1):83-106. 17. Lakoski S, Siscovick D, Herrington D. C-Reactive Protien and Hypertension. Cardiology Review2007. 18. Lakoski SG, Cushman M, Blumenthal RS, Kronmal R, Arnett D, D'Agostino RB, Jr., Detrano RC, Herrington DM. Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. Atherosclerosis. 2007;193(2):401-7. 19. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K, Blumenthal RS. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med. 2007;167(22):2437-42. 20. Lakoski SG, Li L, Langefeld CD, Liu Y, Howard TD, Brosnihan KB, Xu J, Bowden DW, Herrington DM. The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study. Exp Mol Pathol. 2007;82(3):280-3. PMCID: 1995105. 21. Mellen PB, Bittner V, Herrington DM. Post-challenge glucose predicts coronary atherosclerotic progression in non-diabetic, post-menopausal women. Diabet Med. 2007;24(10):1156-9. 22. Mellen PB, Bleyer AJ, Herrington DM. Response to Treatment of Hyperuricemia in Essential Hypertension. Hypertension. 2007. 23. Mellen PB, Goff DC, Jr. Nonpharmacological treatment of hypertension: impact on prevalence estimates. Hypertension. 2007;50(1):e1; author reply e2. 24. Mellen PB, Liese AD, Tooze JA, Vitolins MZ, Wagenknecht LE, Herrington DM. Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr. 2007;85(6):1495-502. 25. Prime DD, Brosnihan KB, Herrington DM. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women. Minerva Cardioangiol. 2007;55(4):477-85. 26. Reeves-Daniel A, Daniel K, Alcorn S, Farney A, Rogers J, Wescott C, Assimos D, Stratta R, Adams P, Hartmann E. Impact of ethnicity on living kidney donation. American Journal of Transplantation. 2007;7:274. 27. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115(18):2390-7. 28. Yeboah J, Reboussin DM, Waters D, Kowalchuk G, Herrington DM. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. Am Heart J. 2007;153(3):439-44. 29. Yeboah J, Sane DC, Crouse JR, Herrington DM, Bowden DW. Low plasma levels of FGF-2 and PDGF-BB are associated with cardiovascular events in type II diabetes mellitus (diabetes heart study). Dis Markers. 2007;23(3):173-8. 30. Daniel KR, Bertoni AG, Ding J, Johnston S, Budoff MJ, Bluemke DA, Carr JJ. Comparison of methods to measure heart size using noncontrast-enhanced computed tomography: correlation with left ventricular mass. J Comput Assist Tomogr. 2008;32(6):934-41. 31. Lai TS, Liu Y, Tucker T, Daniel KR, Sane DC, Toone E, Burke JR, Strittmatter WJ, Greenberg CS. Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chem Biol. 2008;15(9):969-78. PMCID: 2637080. 32. Lakoski S, Herrington D, Wong N, Schreiner P, Blumenthal R. Coronary Calcium as a Predictor of Cardiovascular Events in Low-Risk Women by Framingham Risk Score. Cardiology Review 2008. 33. Lakoski SG, Liu Y, Brosnihan KB, Herrington DM. Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study. Atherosclerosis. 2008;197(1):443-7. PMCID: 2279176. 34. Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, Daniel KR, Herrington DM, Bowden DW. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes. 2008;57(4):1108-14. 35. McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, Hsu FC, Lohman KK, Weinberg RB, Wagenknecht LE. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol. 2008;103(12):3029-35. 36. Mellen PB, Gao SK, Vitolins MZ, Goff DC, Jr. Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004. Arch Intern Med. 2008;168(3):308-14. 37. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2008;18(4):283-90. 38. Nelson MR, Daniel KR, Carr JJ, Freedman BI, Prineas RJ, Bowden DW, Herrington DM. Associations between electrocardiographic interval durations and coronary artery calcium scores: the Diabetes Heart Study. Pacing Clin Electrophysiol. 2008;31(3):314-21. 39. Shah SA. Case: 23 year-old with recurrent seizures (Bechet’s Disease). Medicine/Pediatrics Case-Based Review: McGraw-Hill Specialty Board Review; 2008. 40. Shah SA. Case: 59 year-old with ”ST- Elevation MI” (Takotsubo cardiomyopathy). Medicine/Pediatrics Case-Based Review: McGraw-Hill Specialty Board Review; 2008. 41. Yeboah J, Burke GL, Crouse JR, Herrington DM. Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: the Cardiovascular Health Study. Atherosclerosis. 2008;197(2):840-5. 42. Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Menopause. 2008;15(6):1060-4. 43. Yeboah J, Sutton-Tyrrell K, McBurnie MA, Burke GL, Herrington DM, Crouse JR. Association between brachial artery reactivity and cardiovascular disease status in an elderly cohort: the cardiovascular health study. Atherosclerosis. 2008;197(2):768-76. 44. Cushman M, McClure LA, Howard VJ, Jenny NS, Lakoski SG, Howard G. Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem. 2009;55(9):1627-36. PMCID: 2810186. 45. Daniel KR, Wells G, Stewart K, Moore B, Kitzman DW. Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure. Congest Heart Fail. 2009;15(2):68-74. PMCID: 2922000. 46. Duprez DA, Jacobs DR, Jr., Lutsey PL, Herrington D, Prime D, Ouyang P, Barr RG, Bluemke DA. Race/ethnic and sex differences in large and small artery elasticity--results of the multi-ethnic study of atherosclerosis (MESA). Ethn Dis. 2009;19(3):243-50. PMCID: 2924814. 47. Hall WB, Truitt SG, Scheunemann LP, Shah SA, Rivera MP, Parker LA, Carson SS. The prevalence of clinically relevant incidental findings on chest computed tomographic angiograms ordered to diagnose pulmonary embolism. Arch Intern Med. 2009;169(21):1961-5. 48. Kanjwal Y, John JM, Burket MW. Passing sheaths and electrode catheters through inferior vena cava filters: safer than we think? Catheter Cardiovasc Interv. 2009;74(6):966-9. 49. Lakoski SG, Lagace TA, Cohen JC, Horton JD, Hobbs HH. Genetic and metabolic determinants of plasma PCSK9 levels. J Clin Endocrinol Metab. 2009;94(7):2537-43. PMCID: 2708952. 50. Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Am Heart J. 2009;157(4):688-94. 51. Lehtinen AB, Daniel KR, Shah SA, Nelson MR, Ziegler JT, Freedman BI, Carr JJ, Herrington DM, Langefeld CD, Bowden DW. Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study. Ann Noninvasive Electrocardiol. 2009;14(1):72-9. 52. Minton JA, Tofade TS, Shah SA. Psychosis from Anticholinergic Medications Administered at a Smoking Cessation Clinic. Journal of Pharmacy Practice. 2009;22(October 2009):489-93. 53. Reeves-Daniel A, Freedman BI, Assimos D, Hartmann EL, Bleyer A, Adams PL, Westcott C, Stratta RJ, Rogers J, Farney AC, Daniel KR. Short-term renal outcomes in African American and Caucasian donors following live kidney donation. Clin Transplant. 2009. 54. Rudock ME, Liu Y, Ziegler JT, Allen SG, Lehtinen AB, Freedman BI, Carr JJ, Langefeld CD, Bowden DW. Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study. Atherosclerosis. 2009;203(2):459-65. PMCID: 2699582. 55. Yeboah J. Commentaries on viewpoint: pick your Poiseuille: normalizing the shear stimulus in studies of flow-mediated dilation. J Appl Physiol. 2009;107(4):1360; author reply 6. 56. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation. 2009;120(6):502-9. PMCID: 2740975. 57. Anderson JS, Nettleton JA, Herrington DM, Johnson WC, Tsai MY, Siscovick D. Relation of omega-3 fatty acid and dietary fish intake with brachial artery flow-mediated vasodilation in the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2010;92(5):1204-13. PMCID: 2954452. 58. Bowden DW, Cox AJ, Freedman BI, Hugenschimdt CE, Wagenknecht LE, Herrington D, Agarwal S, Register TD, Maldjian JA, Ng MC, Hsu FC, Langefeld CD, Williamson JD, Carr JJ. Review of the Diabetes Heart Study (DHS) Family of Studies: A Comprehensively Examined Sample for Genetic and Epidemiological Studies of Type 2 Diabetes and its Complications. Rev Diabet Stud. 2010;7(3):188-201. 59. Chen J, Das S, Barlow CE, Grundy S, Lakoski SG. Fitness, fatness, and systolic blood pressure: data from the Cooper Center Longitudinal Study. Am Heart J. 2010;160(1):166-70. 60. Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, Nicklas B, Hamilton C, Hundley WG. Renal Sinus Fat and Poor Blood Pressure Control in Middle-Aged and Elderly Individuals at Risk for Cardiovascular Events. Hypertension. 2010;56(5):901-6. 61. Cushman M, McClure LA, Lakoski SG, Jenny NS. Eligibility for statin therapy by the JUPITER trial criteria and subsequent mortality. Am J Cardiol. 2010;105(1):77-81. PMCID: 2813463. 62. Doran AC, Lehtinen AB, Meller N, Lipinski MJ, Slayton RP, Oldham SN, Skaflen MD, Yeboah J, Rich SS, Bowden DW, McNamara CA. Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans. Circ Res. 2010;106(7):1303-11. PMCID: 2860382. 63. Fu Q, Vangundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, Bhella PS, Levine BD. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2010;55(25):2858-68. PMCID: 2914315. 64. Jeevanantham V, Ntim W, Navaneethan SD, Shah S, Johnson AC, Hall B, Shah A, Hundley WG, Daubert JP, Fitzgerald D. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am J Cardiol. 2010;105(9):1317-26. 65. John JM, Haykowsky M, Brubaker P, Stewart K, Kitzman DW. Decreased left ventricular distensibility in response to postural change in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2010;299(3):H883-9. PMCID: 2944493. 66. John JM, Hussein A, Imran N, Durham SJ, Grubb BP, Kanjwal Y. Underutilization of implantable cardioverter defibrillators post coronary artery bypass grafting in patients with systolic dysfunction. Pacing Clin Electrophysiol. 2010;33(6):727-33. 67. Lakoski SG, Xu F, Vega GL, Grundy SM, Chandalia M, Lam C, Lowe RS, Stepanavage ME, Musliner TA, Cohen JC, Hobbs HH. Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin. J Clin Endocrinol Metab. 2010;95(2):800-9. 68. Liese AD, Nichols M, Hodo D, Mellen PB, Schulz M, Goff DC, D'Agostino RB. Food intake patterns associated with carotid artery atherosclerosis in the Insulin Resistance Atherosclerosis Study. Br J Nutr. 2010;103(10):1471-9. 69. Mellen PB, Daniel KR, Brosnihan KB, Hansen KJ, Herrington DM. Effect of muscadine grape seed supplementation on vascular function in subjects with or at risk for cardiovascular disease: a randomized crossover trial. J Am Coll Nutr. 2010;29(5):469-75. 70. Nettleton JA, McKeown NM, Kanoni S, Lemaitre RN, Hivert MF, Ngwa J, van Rooij FJ, Sonestedt E, Wojczynski MK, Ye Z, Tanaka T, Anderson J. Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care. 2010;33(12):2684-91. PMCID: 2992213. 71. Stacey RB, Bertoni AG, Eng J, Bluemke DA, Hundley WG, Herrington D. Modification of the effect of glycemic status on aortic distensibility by age in the multi-ethnic study of atherosclerosis. Hypertension. 2010;55(1):26-32. 72. Yeboah J, Akosah K, Ailawadi G. Heart failure due to coronary fistulas from the right and left coronary circulation into the right atrium. J Cardiovasc Med (Hagerstown). 2010;11(7):517-8. 73. Yeboah J, McNamara C, Jiang XC, Tabas I, Herrington DM, Burke GL, Shea S. Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(3):628-33. PMCID: 2862629. 74. Agarwal S, Morgan T, Herrington DM, Xu J, Cox AJ, Freedman BI, Carr JJ, Bowden DW. Coronary Calcium Score and Prediction of All-Cause Mortality in Diabetes. Diabetes Care. 2011;34(5):1219-24. 75. Agarwal S, Shlipak MG, Kramer H, Jain A, Herrington DM. The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiol Res Pract. 2011;2012:806102. PMCID: PMC3154776. 76. Agarwal S, Thohan V, Shlipak MG, Lima J, Bluemke DA, Siscovick D, Gomes A, Herrington DM. Association between Cystatin C and MRI Measures of Left Ventricular Structure and Function: Multi-Ethnic Study of Atherosclerosis. Int J Nephrol. 2011;2011:153868. PMCID: 3184416. 77. Anderson JS, Nettleton JA, Hundley WG, Tsai MY, Steffen LM, Lemaitre RN, Siscovick D, Lima J, Prince MR, Herrington D. Associations of plasma phospholipid omega-6 and omega-3 polyunsaturated Fatty Acid levels and MRI measures of cardiovascular structure and function: the multiethnic study of atherosclerosis. J Nutr Metab. 2011;2011:315134. PMCID: 3159987. 78. Berry JD, Willis B, Gupta S, Barlow CE, Lakoski SG, Khera A, Rohatgi A, de Lemos JA, Haskell W, Lloyd-Jones DM. Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal Study. J Am Coll Cardiol. 2011;57(15):1604-10. PMCID: Pmc3608397. 79. Blaha MJ, DeFilippis AP, Rivera JJ, Budoff MJ, Blankstein R, Agatston A, Szklo M, Lakoski SG, Bertoni AG, Kronmal RA, Blumenthal RS, Nasir K. The relationship between insulin resistance and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2011;34(3):749-51. PMCID: Pmc3041221. 80. Blaha MJ, Rivera JJ, Budoff MJ, Blankstein R, Agatston A, O'Leary DH, Cushman M, Lakoski S, Criqui MH, Szklo M, Blumenthal RS, Nasir K. Association between obesity, high-sensitivity C-reactive protein >/=2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31(6):1430-8. PMCID: Pmc3130297. 81. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of Exercise Intolerance in Elderly Heart Failure Patients With Preserved Ejection Fraction. Journal of the American College of Cardiology. 2011;58(3):265-74. doi: 10.1016/j.jacc.2011.02.055. PubMed PMID: WOS:000292453200008. 82. DeFilippis AP, Blaha MJ, Ndumele CE, Budoff MJ, Lloyd-Jones DM, McClelland RL, Lakoski SG, Cushman M, Wong ND, Blumenthal RS, Lima J, Nasir K. The association of Framingham and Reynolds risk scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58(20):2076-83. PMCID: Pmc4079464. 83. Kanoni S, Nettleton JA, Hivert MF, Ye Z, van Rooij FJ, Shungin D, Sonestedt E, Ngwa JS, Wojczynski MK, Lemaitre RN, Gustafsson S, Anderson JS, Tanaka T, Hindy G, Saylor G, Renstrom F, Bennett AJ, van Duijn CM, Florez JC, Fox CS, Hofman A, Hoogeveen RC, Houston DK, Hu FB, Jacques PF, Johansson I, Lind L, Liu Y, McKeown N, Ordovas J, Pankow JS, Sijbrands EJ, Syvanen AC, Uitterlinden AG, Yannakoulia M, Zillikens MC, Wareham NJ, Prokopenko I, Bandinelli S, Forouhi NG, Cupples LA, Loos RJ, Hallmans G, Dupuis J, Langenberg C, Ferrucci L, Kritchevsky SB, McCarthy MI, Ingelsson E, Borecki IB, Witteman JC, Orho-Melander M, Siscovick DS, Meigs JB, Franks PW, Dedoussis GV. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011;60(9):2407-16. PMCID: 3161318. 84. Lakoski SG, Barlow CE, Farrell SW, Berry JD, Morrow JR, Jr., Haskell WL. Impact of body mass index, physical activity, and other clinical factors on cardiorespiratory fitness (from the Cooper Center longitudinal study). Am J Cardiol. 2011;108(1):34-9. 85. Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, Herrington DM. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens. 2011;25(2):73-9. Epub 2010/10/15. doi: 10.1038/jhh.2010.91. PubMed PMID: 20944659; PubMed Central PMCID: PMCPmc4066617. 86. Lakoski SG, Le AH, Muntner P, Judd SE, Safford MM, Levine DA, Howard G, Cushman M. Adiposity, inflammation, and risk for death in black and white men and women in the United States: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Clin Endocrinol Metab. 2011;96(6):1805-14. PMCID: Pmc3100756. 87. Nguyen AB, Rohatgi A, Garcia CK, Ayers CR, Das SR, Lakoski SG, Berry JD, Khera A, McGuire DK, de Lemos JA. Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2011;31(9):2136-43. PMCID: Pmc3177606. 88. Okwuosa TM, Greenland P, Lakoski SG, Ning H, Kang J, Blumenthal RS, Szklo M, Crouse JR, 3rd, Lima JA, Liu K, Lloyd-Jones DM. Factors associated with presence and extent of coronary calcium in those predicted to be at low risk according to Framingham risk score (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2011;107(6):879-85. PMCID: Pmc3182475. 89. Sellers MB, Newby LK. Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J. 2011;161(2):241-6. 90. Shah S. Wake Forest Baptist First Hospital in North Carolina to Implant Newly Approved Device to Treat Heart Failure. American City Business Journals; 2011. 91. Stacey RB, Kock ND, D'Agostino JRB, Torti FM, Eckman DM, Sane DC, Workman S, Lane KS, Hundley WG. Doxorubicin Associated Changes In Coronary Artery Histology. Journal Of The American College Of Cardiology. 2011;57(14s1):E1591-E. 92. Yeboah J. Flaws in Current Clinical Trial Design: Need for Intermediate Markers. J Postgenom Drug Biomark Develop. 2011;1():102e. 93. Yeboah J, Bertoni A, al. e. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events (Reply letter). Journal of American Cardiology 2011;58:2547. 94. Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL. Impaired Fasting Glucose and the Risk of Incident Diabetes Mellitus and Cardiovascular Events in an Adult Population MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58(2):140-6. 95. Yeboah J, Crouse JR, Bluemke DA, Lima JA, Polak JF, Burke GL, Herrington DM. Endothelial dysfunction is associated with left ventricular mass (assessed using MRI) in an adult population (MESA). J Hum Hypertens. 2010. 96. Yeboah J, Nyinaku P. Vitamin D supplementation and cardiovascular outcomes in blacks. Am J Hypertens. 2011;24(5):505. 97. Yeboah J, Redline S, Johnson C, Tracy R, Ouyang P, Blumenthal RS, Burke GL, Herrington DM. Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Atherosclerosis. 2011;219(2):963-8. PMCID: 3255297. 98. Agarwal S, Jacobs DR, Jr., Vaidya D, Sibley CT, Jorgensen NW, Rotter JI, Chen YD, Liu Y, Andrews JS, Kritchevsky S, Goodpaster B, Kanaya A, Newman AB, Simonsick EM, Herrington DM. Metabolic Syndrome Derived from Principal Component Analysis and Incident Cardiovascular Events: The Multi Ethnic Study of Atherosclerosis (MESA) and Health, Aging, and Body Composition (Health ABC). Cardiol Res Pract. 2012:919425. PMCID: 3318892. 99. Barlow CE, DeFina LF, Radford NB, Berry JD, Cooper KH, Haskell WL, Jones LW, Lakoski SG. Cardiorespiratory Fitness and Long-Term Survival in “Low-Risk” Adults. Journal of the American Heart Association. 2012;1(4). doi: 10.1161/jaha.112.001354. 100. Cox A, Agarwal S, Herrington D, Carr J, Freedman B, Bowden D. C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study. Diabet Med. 2012;29(6):767-70. PMCID: PMC Journal - In Process. 101. Kawel N, Nacif M, Arai AE, Gomes AS, Hundley WG, Johnson WC, Prince MR, Stacey RB, Lima JA, Bluemke DA. Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2012;5(3):357-66. PMCID: 3399115. 102. Lakoski SG, Eves ND, Douglas PS, Jones LW. Exercise rehabilitation in patients with cancer. Nat Rev Clin Oncol. 2012;9(5):288-96. 103. Mann DM, Shimbo D, Cushman M, Lakoski S, Greenland P, Blumenthal RS, Michos ED, Lloyd-Jones DM, Muntner P. C-Reactive Protein Level and the Incidence of Eligibility for Statin Therapy: The Multi-Ethnic Study of Atherosclerosis. Clin Cardiol. 2012. 104. Martinez-Rumayor AA, de Lemos JA, Rohatgi AK, Ayers CR, Powell-Wiley TM, Lakoski SG, Berry JD, Khera A, Das SR. Addition of Highly Sensitive Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Electrocardiography for Detection of Left Ventricular Hypertrophy: Results From the Dallas Heart Study. Hypertension. 2012. 105. Mathieu RAt, Powell-Wiley TM, Ayers CR, McGuire DK, Khera A, Das SR, Lakoski SG. Physical activity participation, health perceptions, and cardiovascular disease mortality in a multiethnic population: the Dallas Heart Study. Am Heart J. 2012;163(6):1037-40. PMCID: 3514075. 106. Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, Peralta CA. Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol. 2012;7(7):1137-44. PMCID: 3386670. 107. Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Wann LS, Ward RP, Douglas PS, Altus P, Barnard DD, Blankenship JC, Casey DE, Jr., Dean LS, Fazel R, Gilchrist IC, Kavinsky CJ, Lakoski SG, Le DE, Lesser JR, Levine GN, Mehran R, Russo AM, Sorrentino MJ, Williams MR, Wong JB, Wolk MJ, Hendel RC, Kramer CM, Min JK, Shaw L, Stainback RF, Allen JM. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventions American Association for Thoracic Surgery American Heart Association, American Society of Echocardiography American Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society, Society of Critical Care Medicine Society of Cardiovascular Computed Tomography Society for Cardiovascular Magnetic Resonance Society of Thoracic Surgeons. Catheter Cardiovasc Interv. 2012;80(3):E50-81. 108. Powell-Wiley TM, Ayers CR, Banks-Richard K, Berry JD, Khera A, Lakoski SG, McGuire DK, de Lemos JA, Das SR. Disparities in counseling for lifestyle modification among obese adults: insights from the Dallas Heart Study. Obesity (Silver Spring). 2012;20(4):849-55. PMCID: Pmc3514073. 109. Ren J, Lakoski S, Haller RG, Sherry AD, Malloy CR. Dynamic monitoring of carnitine and acetylcarnitine in the trimethylamine signal after exercise in human skeletal muscle by 7T (1) H-MRS. Magn Reson Med. 2012. 110. Riley R, Don C, Aldea G, Mokadam N, Probstfield J, Maynard C, Goss J. Recent Trends in Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry. Journal of the American Heart Association. 2012;1(5). PMCID: PMC Journal - In Process. 111. Yeboah J. Predicting Heart Attack Risk: A Calcium Test May Help. Time, Inc.; 2012 [updated 2012; cited August 22, 2012]; Available from. 112. Yeboah J. Which Heart Risk Test Rates Best? : WebMD, LLC; 2012 [updated 2012; cited August 21, 2012]; Available from. 113. Yeboah J. 2 Tests May Improve Heart Patients' Care, Studies Suggest. US News and World Report, LP; 2012 [updated 2012; cited August 21, 2012]; Available from. 114. Yeboah J. Cardiovascular Risk Prediction: Two More Studies, Little Progress. Forbes.com, LLC; 2012 [updated 2012; cited August 21, 2012]; Available from. 115. Yeboah J. Targeting specific traditional risk factors to improve cardiovascular outcomes: Sound or flawed? Atherosclerosis. 2013;226(2):335-6. 116. Yeboah J, Greenland P, Herrington DM. Markers for prediction of cardiovascular disease risk—reply. JAMA. 2012;308(24):2561-2. 117. Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC, Greenland P, Herrington DM. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308(8):788-95. PMCID: PMC Journal - In Process. 118. Yeboah J, Rodriguez CJ, Stacey B, Lima JA, Liu S, Carr JJ, Hundley WG, Herrington DM. Prognosis of Individuals with Asymptomatic Left Ventricular Systolic Dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2012;126(23):2713-9. PMCID: 3533250. 119. Agarwal S, Cox AJ, Herrington DM, Jorgensen NW, Xu J, Freedman BI, Carr JJ, Bowden DW. Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study. Diabetes Care. 2013;36(4):972-7. PMCID: 3609509. 120. Ahmed HM, Blaha MJ, Nasir K, Jones SR, Rivera JJ, Agatston A, Blankstein R, Wong ND, Lakoski S, Budoff MJ, Burke GL, Sibley CT, Ouyang P, Blumenthal RS. Low-risk lifestyle, coronary calcium, cardiovascular events, and mortality: results from MESA. Am J Epidemiol. 2013;178(1):12-21. PMCID: 3698994. 121. Clavel MA, Messika-Zeitoun D, Pibarot P, Aggarwal S, Malouf J, Araoz P, Michelena H, Cueff C, Larose E, Capoulade R, Vahanian A, Enriquez-Sarano M. The complex nature of Discordant Severe Calcified Aortic Valve Disease Grading: New Insights from combined Doppler-Echocardiographic and Computed Tomographic Study. J Am Coll Cardiol. 2013. 122. Cox A, Hugenschmidt CE, Wang P, Hsu F, Kenchaiah S, Daniel K, Freedman B, Herrington D, Carr J, Stacey B, Bowden D. Biventricular volume is an independent predictor of mortality in the Diabetes Heart Study. American Journal of Cardiology. 2013;111(8):1152-8 123. Dawood FZ, Khan F, Roediger MP, Zhang ZM, Swaminathan S, Klinker H, Hoy J, Lundgren JD, Neaton JD, Soliman EZ. Electrocardiographic spatial QRS-T angle and incident cardiovascular disease in HIV-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] study). Am J Cardiol. 2013;111(1):118-24. PMCID: 3525800. 124. Eckman DM, Stacey RB, Rowe R, D'Agostino R, Jr., Kock ND, Sane DC, Torti FM, Yeboah J, Workman S, Lane KS, Hundley WG. Weekly doxorubicin increases coronary arteriolar wall and adventitial thickness. PLoS One. 2013;8(2):e57554. PMCID: 3578811. 125. Hassan SA, Amer S, Qureshi W, Alirhayim Z, Kuriakose P. Treating symptomatic coronary artery disease in patients with Von Willebrand disease. Hematol Oncol Stem Cell Ther. 2013; 6(3-4):101-4. 126. Khalid F, Qureshi W, Qureshi S, Alirhayim Z, Garikapati K, Patsias I. Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage. Ren Fail. 2013;35(9):1228-35. 127. Lakoski SG. Fitness protects you from cancer, even 20 years later 2013 [updated 2013; cited]; Available from. 128. Lakoski SG, Barlow CE, Koelwyn GJ, Hornsby WE, Hernandez J, Defina LF, Radford NB, Thomas SM, Herndon JE, 2nd, Peppercorn J, Douglas PS, Jones LW. The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study. Breast Cancer Res Treat. 2013;138(3):909-16. PMCID: 3640334. 129. Lakoski SG, Mallick H, McClure LA, Safford M, Kissela B, Howard G, Cushman M. A risk algorithm for assessing short-term mortality for obese black and white men and women. Obesity (Silver Spring). 2013. 130. Li Y, Dawood FZ, Chen H, Jain A, Walsh JA, 3rd, Alonso A, Lloyd-Jones DM, Soliman EZ. Minor isolated Q waves and cardiovascular events in the MESA study. Am J Med. 2013;126(5):450 e9- e16. PMCID: 3741651. 131. Powell-Wiley TM, Ayers CR, de Lemos JA, Lakoski SG, Vega GL, Grundy S, Das SR, Banks-Richard K, Albert MA. Relationship between perceptions about neighborhood environment and prevalent obesity: data from the Dallas Heart Study. Obesity (Silver Spring). 2013;21(1):E14-21. PMCID: 3602329. 132. Qureshi W, Blaha MJ, Nasir K, Al-Mallah MH. Gender differences in coronary plaque composition and burden detected in symptomatic patients referred for coronary computed tomographic angiography. The international journal of cardiovascular imaging. 2013;29(2):463-9. 133. Qureshi W, Hassan S, Khalid F, Almahmoud MF, Shah B, Tashman R, Ambulgekar N, El-Refai M, Mittal C, Alirhayim Z. Outcomes of correcting hyponatremia in patients with myocardial infarction. Clin Res Cardiol. 2013;102(9):637-44. 134. Qureshi W, Khalid F. Prevention is Better than Cure – Preventing Chemotherapy Induced Cardiomyopathy. J Cardiol Clin Res. 2013;1:1006. 135. Riley RF, Newby LK, Don CW, Alexander KP, Peterson ED, Peng SA, Gandhi SK, Kutcher MA, Amsterdam EA, Herrington DM. Guidelines-based treatment of anaemic STEMI patients: practice patterns and effects on in-hospital mortality: a retrospective analysis from the NCDR. European Heart Journal: Acute Cardiovascular Care. 2013;2(1):35-43. 136. Riley RF, Newby LK, Don CW, Roe MT, Holmes DN, Gandhi SK, Kutcher MA, Herrington DM. Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Am Heart J. 2013;165(1):50-6. PMCID: 3523309. 137. Samsky M, Patel CB, Owen A, Schulte PJ, Jentzer J, Rosenberg PB, Felker GM, Milano CA, Hernandez AF, Rogers JG. Ten Year Experience with Extended Criteria Cardiac Transplantation. Circ Heart Fail. 2013;6(6):1230-8. 138. Savage PD, Lakoski SG, Ades PA. Course of body weight from hospitalization to exit from cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2013;33(5):274-80. 139. Scott JM, Lakoski S, Mackey JR, Douglas PS, Haykowsky MJ, Jones LW. The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics. Oncologist. 2013;18(2):221-31. PMCID: 3579607. 140. Shah SA, Herrington DM, Howard TD, Divers J, Arnett DK, Burke GL, Kao WH, Guo X, Siscovick DS, Chakravarti A, Lima JA, Psaty BM, Tomaselli GF, Rich SS, Bowden DW, Post W. Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA). Ann Noninvasive Electrocardiol. 2013;18(1):29-40. PMCID: PMC3642094. 141. Shah SA, Kambur T, Chan C, Herrington DM, Liu K, Shah SJ. Relation of Short-Term Heart Rate Variability to Incident Heart Failure (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2013. PMCID: PMC3735865. 142. Stacey RB, Hundley WG. The Role of Cardiovascular Magnetic Resonance (CMR) and Computed Tomography (CCT) in Facilitating Heart Failure Management. Curr Treat Options Cardiovasc Med. 2013;15(4):373-86. PMCID: 3767383. 143. Upadhya B, Ntim W, Brandon Stacey R, Henderson R, Leedy D, O'Brien FX, Knovich MA. Prolongation of QTc intervals and risk of death among patients with sickle cell disease. Eur J Haematol. 2013;91(2):170-8. 144. Yeboah J. Targeting specific traditional risk factors to improve cardiovascular outcomes: Sound or flawed? Atherosclerosis. 2013;226(2):335-6. 145. Yeboah J, Carr JJ, Terry JG, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff MJ. Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2013. 146. Yeboah J, Herrington DM. Intermediate end point cardiovascular clinical trials: an excellent idea based on an obsolete paradigm. Expert Rev Cardiovasc Ther. 2013. 147. Yeboah J. Coronary Artery Calcium Scores Identify People at Risk for Heart Attacks. The MESA Messenger-Newsletter of the Multi-Ethnic Study of Atherosclerosis. 2013 148. Ahmed FS, Jiang XC, Schwartz JE, Hoffman EA, Yeboah J, Shea S, Burkart KM, Barr RG. Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA lung study. Biomarkers. 2014;19(3):207-13. PMCID: 4088962. 149. Al-Mallah MH, Qureshi W, Lin FY, Achenbach S, Berman DS, Budoff MJ, Callister TQ, Chang HJ, Cademartiri F, Chinnaiyan K, Chow BJ, Cheng VY, Delago A, Gomez M, Hadamitzky M, Hausleiter J, Kaufmann PA, Leipsic J, Maffei E, Raff G, Shaw LJ, Villines TC, Cury RC, Feuchtner G, Plank F, Kim YJ, Dunning AM, Min JK. Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry. Eur Heart J Cardiovasc Imaging. 2014;15(3):267-74. 150. Al-Mallah MH, Qureshi W, Pantelic M, Nour K. Long term prognostic value of Coronary Computed Tomography Angiography in suspected coronary artery disease: a 62 month median follow-up study. Int J Cardiol. 2014;176(3):1244-6. 151. Balfour PC, Jr., Rodriguez CJ, Ferdinand KC. Blood pressure and cardiovascular effects of new and emerging antidiabetic agents. Curr Hypertens Rep. 2014;16(8):455. 152. Berkman A, B FC, Ades PA, Dickey S, Higgins ST, Trentham-Dietz A, Sprague BL, Lakoski SG. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2014;148(2):407-13. PMCID: Pmc4372117. 153. Cox AJ, Azeem A, Yeboah J, Soliman EZ, Aggarwal SR, Bertoni AG, Carr JJ, Freedman BI, Herrington DM, Bowden DW. Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Diabetes Care. 2014;37(5):1454-61. PMCID: Pmc4182905. 154. Cox AJ, Hsu FC, Agarwal S, Freedman BI, Herrington DM, Carr JJ, Bowden DW. Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study. Cardiovascular diabetology. 2014;13:160. PMCID: Pmc4266952. 155. Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF, Lundgren JD, Neaton JD, Soliman EZ. Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study. J Electrocardiol. 2014;47(2):264-71. PMCID: 3951578. 156. Gibson AO, Blaha MJ, Arnan MK, Sacco RL, Szklo M, Herrington DM, Yeboah J. Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. JACC Cardiovasc Imaging. 2014;7(11):1108-15. PMCID: 4254694. 157. Hassan M, Qureshi W, Sroujieh LS, Albashaireh D, BouMalham S, Liroff M, Amjad W, Khalid F, Hadid H, Alirhayim Z. Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease. J Renin Angiotensin Aldosterone Syst. 2014. 158. Howard TD, Mathias RA, Seeds MC, Herrington DM, Hixson JE, Shimmin LC, Hawkins GA, Sellers M, Ainsworth HC, Sergeant S, Miller LR, Chilton FH. DNA methylation in an enhancer region of the FADS cluster is associated with FADS activity in human liver. PLoS One. 2014;9(5):e97510. PMCID: Pmc4026313. 159. Jordan JH, Haag JC, Morgan TM, Vasu S, Stacey B, Hamilton C, Robinson K, Kitzman D, Thohan V, Hundley WG. Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging. J Comput Assist Tomogr. 2014;38(3):427-33. PMCID: 4103171. 160. Lakoski SG, Kozlitina J. Ethnic differences in physical activity and metabolic risk: the Dallas Heart Study. Med Sci Sports Exerc. 2014;46(6):1124-32. 161. Manichaikul A, Rich SS, Perry H, Yeboah J, Law M, Davis M, Parker M, Ragosta M, Connelly JJ, McNamara CA, Taylor AM. A Functionally Significant Polymorphism in ID3 Is Associated with Human Coronary Pathology. PLoS One. 2014;9(3):e90222. 162. Mittal C, Qureshi W, Singla S, Ahmad U, Huang MA. Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure. Dig Dis Sci. 2014;59(3):674-80. 163. O'Neal WT, Efird JT, Dawood FZ, Yeboah J, Alonso A, Heckbert SR, Soliman EZ. Coronary artery calcium and risk of atrial fibrillation (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2014;114(11):1707-12. PMCID: Pmc4253067. 164. O'Neal WT, Efird JT, Yeboah J, Nazarian S, Alonso A, Heckbert SR, Soliman EZ. Brachial flow-mediated dilation and incident atrial fibrillation: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(12):2717-20. PMCID: Pmc4239189. 165. Peel AB, Thomas SM, Dittus K, Jones LW, Lakoski SG. Cardiorespiratory fitness in breast cancer patients: a call for normative values. J Am Heart Assoc. 2014;3(1):e000432. PMCID: 3959685. 166. Qureshi W, Alirhayim Z, Khalid F. Letter by Qureshi et al regarding article, "Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis". Circulation. 2014;130(25):e427. 167. Qureshi W, Mittal C, Patsias I, Garikapati K, Kuchipudi A, Cheema G, Elbatta M, Alirhayim Z, Khalid F. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol. 2014;113(4):662-8. 168. Qureshi W, Shah AJ, Salahuddin T, Soliman EZ. Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2014;114(1):59-64. PMCID: Pmc4334655. 169. Qureshi W, Soliman EZ, Solomon SD, Alonso A, Arking DE, Shah A, Gupta DK, Wagenknecht LE, Herrington D. Risk factors for atrial fibrillation in patients with normal versus dilated left atrium (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2014;114(9):1368-72. PMCID: 4195803. 170. Qureshi W, Yeboah J. Metabolomics: The-Omics of Tomorrow. Metabolomics. 2014;4:e130. 171. Raffield LM, Agarwal S, Cox AJ, Hsu FC, Carr JJ, Freedman BI, Xu J, Bowden DW, Vitolins MZ. Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the Diabetes Heart Study. Am J Clin Nutr. 2014;100(4):1029-35. PMCID: Pmc4163793. 172. Rossi JS, Cammarata M, Dharmavaram J, Weck K, Walko C, Gabriel D, Kuritzky J, Muldrew K, Stouffer GA. Clopidogrel dose adjustment after outpatient screening for CYP2C19 variant alleles: a pilot study. Pharmacogenomics. 2014;15(7):915-23 173. Scott JM, Jones LW, Hornsby WE, Koelwyn GJ, Khouri MG, Joy AA, Douglas PS, Lakoski SG. Cancer therapy-induced autonomic dysfunction in early breast cancer: implications for aerobic exercise training. Int J Cardiol. 2014;171(2):e50-1. PMCID: 4116686. 174. Soliman EZ, Cammarata M, Li Y. Explaining the inconsistent associations of PR interval with mortality: The role of P-duration contribution to the length of PR interval. Heart Rhythm. 2014;11(1):93-8. 175. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174(1):107-14. PMCID: Pmc4115282. 176. Stacey RB, Andersen M, Haag J, Hall ME, McLeod G, Upadhya B, Hundley WG, Thohan V. Right ventricular morphology and systolic function in left ventricular noncompaction cardiomyopathy. Am J Cardiol. 2014;113(6):1018-23. PMCID: 3969853. 177. Stacey RB, Haag J, Hall ME, McLeod G, Upadhya B, Hundley WG, Thohan V. Mitral regurgitation in left ventricular noncompaction cardiomyopathy assessed by cardiac MRI. J Heart Valve Dis. 2014;23(5):591-7. 178. Stacey RB, Haag J, Hall ME, McLeod G, Upadhya B, Hundley WG, Thohan V. Mitral regurgitation in left ventricular noncompaction cardiomyopathy assessed by cardiac MRI. J Heart Valve Dis. 2014;23(5):591-7. 179. Upadhya B, Stacey RB, Ntim W, Knovich MA, Pu M. Echocardiography-derived tricuspid regurgitant jet velocity is an important marker for the progression of sickle-cell disease. Acta Haematol. 2014;132(2):152-8. 180. Yeboah J. Cardiovascular risk prediction: the old has given way to the new but at what risk benefit ratio? Research Reports in Clinical Cardiology. 2014;5:279-81. 181. Yeboah J, Bluemke DA, Hundley WG, Rodriguez CJ, Lima JA, Herrington DM. Left ventricular dilation and incident congestive heart failure in asymptomatic adults without cardiovascular disease: multi-ethnic study of atherosclerosis (MESA). Journal of cardiac failure. 2014;20(12):905-11. PMCID: Pmc4250423. 182. Yeboah J, Delaney JA, Nance R, McClelland RL, Polak JF, Sibley CT, Bertoni A, Burke GL, Carr JJ, Herrington DM. Mediation of cardiovascular risk factor effects through subclinical vascular disease: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(8):1778-83. 183. Yeboah J, Erbel R, Delaney JC, Nance R, Guo M, Bertoni AG, Budoff M, Moebus S, Jöckel K-H, Burke GL, Wong ND, Lehmann N, Herrington DM, Möhlenkamp S, Greenland P. Development of a New Diabetes Risk Prediction Tool for Incident Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis. 2014;Published online August 13, 2014; http://dx.doi.org/10.1016/j.atherosclerosis.2014.07.035. 184. Almahmoud MF, O'Neal WT, Qureshi W, Soliman EZ. Electrocardiographic Versus Echocardiographic Left Ventricular Hypertrophy in Prediction of Congestive Heart Failure in the Elderly. Clin Cardiol. 2015. 185. Alonso A, Yu B, Qureshi WT, Grams ME, Selvin E, Soliman EZ, Loehr LR, Chen LY, Agarwal SK, Alexander D, Boerwinkle E. Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study. PLoS One. 2015;10(11):e0142610. PMCID: Pmc4636390. 186. Arnan MK, Hsieh TC, Yeboah J, Bertoni AG, Burke GL, Bahrainwala Z, Grega MA, Baumgartner WA, Gottesman RF. Postoperative blood urea nitrogen is associated with stroke in cardiac surgical patients. The Annals of thoracic surgery. 2015;99(4):1314-20. 187. Balfour PC, Jr., Rodriguez CJ, Ferdinand KC. The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease. Current cardiovascular risk reports. 2015;9(4). PMCID: Pmc4577235. 188. Beg MS, Saleem S, Turer A, Ayers C, de Lemos JA, Khera A, Scherer PE, Lakoski SG. A Prospective Analysis of Plasma Adiponectin and Risk of Incident Cancer: The Dallas Heart Study. Journal of the National Comprehensive Cancer Network : JNCCN. 2015;13(7):873-8. 189. Berkman AM, Lakoski SG. Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer. J Am Heart Assoc. 2015;4(4). PMCID: Pmc4579959. 190. Berkman AM, Lakoski SG. The potential of aerobic exercise training in mitigating cardiovascular side effects of cancer therapy. Future Cardiol. 2015;11(4):407-11. 191. Berkman AM, Trentham-Dietz A, Dittus K, Hart V, Vatovec CM, King JG, James TA, Lakoski SG, Sprague BL. Health behavior change following a diagnosis of ductal carcinoma in situ: An opportunity to improve health outcomes. Preventive medicine. 2015;80:53-9. PMCID: Pmc4592364. 192. Cammarata M, Kon N, Zhao D. Should the CMS NCD Requirement for Surgeon and Interventional Co-Operators for TAVR Procedures be Dropped? Cardiac Interventions Today. 2015(9):68-72. 193. Chacko BG, Edwards MS, Sharrett AR, Qureshi WT, Klein BE, Klein R, Herrington DM, Soliman EZ. Microvasculature and incident atrioventricular conduction abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA). Vascular medicine (London, England). 2015;20(5):417-23. 194. Chahal H, Bluemke DA, Wu CO, McClelland R, Liu K, Shea SJ, Burke G, Balfour P, Herrington D, Shi P, Post W, Olson J, Watson KE, Folsom AR, Lima JA. Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis. Heart (British Cardiac Society). 2015;101(1):58-64. PMCID: Pmc4685458. 195. Chotenimitkhun R, D'Agostino R, Jr., Lawrence JA, Hamilton CA, Jordan JH, Vasu S, Lash TL, Yeboah J, Herrington DM, Hundley WG. Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function. The Canadian journal of cardiology. 2015;31(3):302-7. PMCID: Pmc4410009. 196. Dittus KL, Lakoski SG, Savage PD, Kokinda N, Toth M, Stevens D, Woods K, O'Brien P, Ades PA. Exercise-based oncology rehabilitation: leveraging the cardiac rehabilitation model. J Cardiopulm Rehabil Prev. 2015;35(2):130-9. PMCID: Pmc4342296. 197. Drake SM, Qureshi W, Morse W, Baker-Genaw K. A time-efficient web-based teaching tool to improve medical knowledge and decrease ABIM failure rate in select residents. Medical education online. 2015;20:29221. PMCID: Pmc4628945. 198. Forbang NI, Allison MA, Ix JH, Criqui MH, Vaidya D, Yeboah J, Duprez DA, Jacobs DR, Jr. Associations of body composition measures and C2, a marker for small artery elasticity: The MESA. Obesity (Silver Spring). 2015;23(11):2294-8. PMCID: Pmc4633382. 199. Gonzalez JA, Balfour PC, Jr., Shaw PW. The Cardiac Imaging Specialist: Pursuing Further Training. J Am Coll Cardiol. 2015;66(22):2563-8. 200. Juraschek SP, Blaha MJ, Blumenthal RS, Brawner C, Qureshi W, Keteyian SJ, Schairer J, Al-Mallah MH. Cardiorespiratory Fitness and Incident Diabetes: The FIT (Henry Ford Exercise Testing) Project. Diabetes Care. 2015. 201. Lakoski SG, Jones LW, Krone RJ, Stein PK, Scott JM. Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms. Am Heart J. 2015;170(2):231-41. PMCID: Pmc4548856. 202. Lakoski SG, Savage PD, Berkman AM, Penalosa L, Crocker A, Ades PA, Kahn SR, Cushman M. The safety and efficacy of early-initiation exercise training after acute venous thromboembolism: a randomized clinical trial. Journal of thrombosis and haemostasis : JTH. 2015;13(7):1238-44. 203. Lakoski SG, Willis BL, Barlow CE, Leonard D, Gao A, Radford NB, Farrell SW, Douglas PS, Berry JD, DeFina LF, Jones LW. Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in Men: The Cooper Center Longitudinal Study. JAMA oncology. 2015;1(2):231-7. 204. Lin GM, Colangelo LA, Lloyd-Jones DM, Redline S, Yeboah J, Heckbert SR, Nazarian S, Alonso A, Bluemke DA, Punjabi NM, Szklo M, Liu K. Association of Sleep Apnea and Snoring With Incident Atrial Fibrillation in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2015;182(1):49-57. PMCID: Pmc4479113. 205. Mahler SA, Riley RF, Hiestand BC, Russell GB, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Elliott SB, Herrington DM, Burke GL, Miller CD. The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge. Circulation Cardiovascular quality and outcomes. 2015;8(2):195-203. PMCID: Pmc4413911. 206. Milks MW, Upadhya B, Hall ME, Vasu S, Hundley WG, Stacey RB. Right ventricular stress-induced perfusion defects and late gadolinium enhancement in coronary artery disease. J Comput Assist Tomogr. 2015;39(2):185-8. 207. Olson NC, Cushman M, Judd SE, McClure LA, Lakoski SG, Folsom AR, Safford MM, Zakai NA. American Heart Association's Life's Simple 7 and Risk of Venous Thromboembolism: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. J Am Heart Assoc. 2015;4(3). 208. O'Neal WT, Almahmoud MF, Qureshi WT, Soliman EZ. Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2015;24(9):1991-7. 209. O'Neal WT, Efird JT, Qureshi WT, Yeboah J, Alonso A, Heckbert SR, Nazarian S, Soliman EZ. Coronary Artery Calcium Progression and Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2015;8(12). PMCID: Pmc4681308. 210. O'Neal WT, Lakoski SG, Qureshi W, Judd SE, Howard G, Howard VJ, Cushman M, Soliman EZ. Relation between cancer and atrial fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study). Am J Cardiol. 2015;115(8):1090-4. PMCID: 4380860. 211. O'Neal WT, Qureshi W, Judd SE, Glasser SP, Ghazi L, Pulley L, Howard VJ, Howard G, Soliman EZ. Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2015;49(6):802-8. 212. O'Neal WT, Qureshi W, Li Y, Soliman EZ. RSR' pattern and the risk of mortality in men and women free of cardiovascular disease. J Electrocardiol. 2015;48(3):430-3. 213. O'Neal WT, Qureshi WT, Blaha MJ, Ehrman JK, Brawner CA, Nasir K, Al-Mallah MH. Relation of Risk of Atrial Fibrillation With Systolic Blood Pressure Response During Exercise Stress Testing (from the Henry Ford ExercIse Testing Project). Am J Cardiol. 2015;116(12):1858-62. 214. O'Neal WT, Qureshi WT, Blaha MJ, Keteyian SJ, Brawner CA, Al-Mallah MH. Systolic Blood Pressure Response During Exercise Stress Testing: The Henry Ford ExercIse Testing (FIT) Project. J Am Heart Assoc. 2015;4(5). 215. O'Neal WT, Qureshi WT, Judd SE, Bowling CB, Howard VJ, Howard G, Soliman EZ. Effect of Falls on Frequency of Atrial Fibrillation and Mortality Risk (from the REasons for Geographic And Racial Differences in Stroke Study). Am J Cardiol. 2015;116(8):1213-8. PMCID: Pmc4589487. 216. O'Neal WT, Qureshi WT, Judd SE, McClure LA, Cushman M, Howard VJ, Howard G, Soliman EZ. Environmental Tobacco Smoke and Atrial Fibrillation: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine. 2015;57(11):1154-8. PMCID: Pmc4636018. 217. O'Neal WT, Soliman EZ, Qureshi W, Alonso A, Heckbert SR, Herrington D. Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. J Am Soc Hypertens. 2015;9(3):191-6. PMCID: 4369319. 218. Pandey A, Parashar A, Kumbhani DJ, Agarwal S, Garg J, Kitzman D, Levine BD, Drazner M, Berry JD. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail. 2015;8(1):33-40. 219. Peel AB, Barlow CE, Leonard D, DeFina LF, Jones LW, Lakoski SG. Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers: The Cooper Center Longitudinal Study. Gynecologic oncology. 2015;138(2):394-7. 220. Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH. Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results from the Henry Ford ExercIse Tesing (FIT) Project. Circulation. 2015. 221. Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH. Response to Letter Regarding Article, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project". Circulation. 2015;132(25):e395. 222. Qureshi WT, Alirhayim Z, Khalid F, Al-Mallah MH. Prognostic value of extracardiac incidental findings on attenuation correction cardiac computed tomography. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2015. 223. Qureshi WT, Keteyian SJ, Brawner CA, Dardari Z, Blaha MJ, Al-Mallah MH. Impact of statin use on cardiorespiratory fitness in multi-racial men and women: The Henry Ford Exercise Testing (FIT) Project. Int J Cardiol. 2015;197:76-7. 224. Qureshi WT, Nasir K, Hacioglu Y, Sibley CT, Gupta M, Rivera JJ, Blumenthal R, Katz R, Budoff MJ. Determination and distribution of left ventricular size as measured by noncontrast CT in the Multi-Ethnic Study of Atherosclerosis. Journal of cardiovascular computed tomography. 2015;9(2):113-9. 225. Qureshi WT, Nasir UB, Alqalyoobi S, O'Neal WT, Mawri S, Sabbagh S, Soliman EZ, Al-Mallah MH. Meta-Analysis of Continuous Positive Airway Pressure as a Therapy of Atrial Fibrillation in Obstructive Sleep Apnea. Am J Cardiol. 2015;116(11):1767-73. 226. Qureshi WT, O'Neal WT, Khodneva Y, Judd S, Safford MM, Muntner P, Soliman EZ. Association Between Opioid Use and Atrial Fibrillation: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. JAMA Intern Med. 2015. 227. Qureshi WT, Rana JS, Yeboah J, Bin Nasir U, Al-Mallah MH. Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium. Current cardiology reports. 2015;17(12):110. 228. Stacey RB, Caine AJ, Jr., Hundley WG. Evaluation and management of left ventricular noncompaction cardiomyopathy. Current heart failure reports. 2015;12(1):61-7. 229. Stacey RB, Leaverton PE, Schocken DD, Peregoy JA, Bertoni AG. Prediabetes and the association with unrecognized myocardial infarction in the multi-ethnic study of atherosclerosis. Am Heart J. 2015;170(5):923-8. 230. Stacey RB, Milks MW, Deutsch C, Upadhya B, Hundley WG, Thohan V. Clinical significance of intermediate left ventricular trabeculations in cardiac magnetic resonance. Acta cardiologica. 2015;70(5):588-93. 231. Stopyra JP, Miller CD, Hiestand BC, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Riley RF, Russell GB, Hoekstra JW, Mahler SA. Performance of the EDACS-accelerated Diagnostic Pathway in a Cohort of US Patients with Acute Chest Pain. Critical pathways in cardiology. 2015;14(4):134-8. PMCID: Pmc4648698. 232. Thompson HJ, Sedlacek SM, Playdon MC, Wolfe P, McGinley JN, Paul D, Lakoski SG. Weight loss interventions for breast cancer survivors: impact of dietary pattern. PLoS One. 2015;10(5):e0127366. PMCID: Pmc4443974. 233. Tota-Maharaj R, Al-Mallah MH, Nasir K, Qureshi WT, Blumenthal RS, Blaha MJ. Improving the relationship between coronary artery calcium score and coronary plaque burden: addition of regional measures of coronary artery calcium distribution. Atherosclerosis. 2015;238(1):126-31. 234. Vasu S, Little WC, Morgan TM, Stacey RB, Ntim WO, Hamilton C, Thohan V, Chiles C, Hundley WG. Mechanism of decreased sensitivity of dobutamine associated left ventricular wall motion analyses for appreciating inducible ischemia in older adults. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2015;17:26. PMCID: Pmc4389511. 235. Vasu S, Morgan TM, Kitzman DW, Bertoni A, Stacey RB, Hamilton C, Chiles C, Thohan V, Hundley WG. Abnormal stress-related measures of arterial stiffness in middle-aged and elderly men and women with impaired fasting glucose at risk for a first episode of symptomatic heart failure. J Am Heart Assoc. 2015;4(1):e000991. PMCID: Pmc4330048. 236. Whitlock MC, Yeboah J, Burke GL, Chen H, Klepin HD, Hundley WG. Cancer and Its Association With the Development of Coronary Artery Calcification: An Assessment From the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2015;4(11). 237. Yeboah J. Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention. Evidence-based medicine. 2015;20(6):230. 238. Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC, Jr., Psaty BM, Greenland P, Herrington DM. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circulation. 2015;132(10):916-22. PMCID: Pmc4567414. 239. Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2015;169(3):387-95 e3. PMCID: 4347939. 240. Zulqarnain MA, Qureshi WT, O'Neal WT, Shah AJ, Soliman EZ. Risk of Mortality Associated With QT and JT Intervals at Different Levels of QRS Duration (from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2015. 241. Dharod A, Soliman EZ, Dawood F, Chen H, Shea S, Nazarian S, Bertoni AG. Association of Asymptomatic Bradycardia With Incident Cardiovascular Disease and Mortality: The Multi-Ethnic Study of Atherosclerosis (MESA). JAMA Intern Med. 2016;176(2):219-27. 242. Hall ME, Brinkley TE, Chughtai H, Morgan TM, Hamilton CA, Jordan JH, Stacey RB, Soots S, Hundley WG. Adiposity Is Associated with Gender-Specific Reductions in Left Ventricular Myocardial Perfusion during Dobutamine Stress. PLoS One. 2016;11(1):e0146519. PMCID: Pmc4709095. 243. Khadanga S, Lakoski SG, Hart V, Sprague BL, Ba Y, Hampton JM, Higgins ST, Ades PA, Newcomb PA, Trentham-Dietz A. Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;25(1):76-82. PMCID: Pmc4713311. 244. Mahler SA, Riley RF, Russell GB, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Bringolf J, Elliott SB, Herrington DM, Burke GL, Miller CD. Adherence to an Accelerated Diagnostic Protocol for Chest Pain: Secondary Analysis of the HEART Pathway Randomized Trial. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2016;23(1):70-7. PMCID: Pmc4716613. 245. Ohyama Y, Teixido-Tura G, Ambale-Venkatesh B, Noda C, Chugh AR, Liu CY, Redheuil A, Stacey RB, Dietz H, Gomes AS, Prince MR, Evangelista A, Wu CO, Hundley WG, Bluemke DA, Lima JA. Ten-year longitudinal change in aortic stiffness assessed by cardiac MRI in the second half of the human lifespan: the multi-ethnic study of atherosclerosis. Eur Heart J Cardiovasc Imaging. 2016. 246. Qureshi WT, Leigh JA, Swett K, Dharod A, Allison MA, Cai J, Gonzalez F, 2nd, Hurwitz BE, Shah SJ, Desai AA, Spevack DM, Rodriguez CJ. Comparison of Echocardiographic Measures in a Hispanic/Latino Population With the 2005 and 2015 American Society of Echocardiography Reference Limits (The Echocardiographic Study of Latinos). Circ Cardiovasc Imaging. 2016;9(1). PMCID: Pmc4696402. 247. Stacey R, Meng M, Byrum G, Gilbert O, Upadyha B, Rodriguez C, Zhao D, Pu M. Clinical Outcomes In Different Types of Aortic Stenosis: A Single-Center Experience American Journal of Cardiology-Under Review. 2016. 248. Yeboah J, Young R, McClelland RL, Delaney JC, Polonsky TS, Dawood FZ, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC, Jr., Psaty BM, Greenland P, Herrington DM. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol. 2016;67(2):139-47. PMCID: Pmc4724058. Book Chapters: 1. Shah SA. Case: 23 year-old with recurrent seizures (Bechet’s Disease). Medicine/Pediatrics Case-Based Review. AJ Liles and RM Wardrop. McGraw-Hill Specialty Board Review. 2008: Vol1. 2. Humphrey H, Shah SA, and Shah S. Case: 59 year-old with ”ST- Elevation MI” (Takotsubo cardiomyopathy). Medicine/Pediatrics Case-Based Review. AJ Liles and RM Wardrop. McGraw-Hill Specialty Board Review. 2008: Vol1. 3. Waqas Qureshi, David M. Herrington. Metabolomics in Cardiovascular Disease. In Annabelle Rodriguez-Oquendo eds. Translational Cardiometabolic Genomic Medicine Elsevier Publications, September, 2015 (pp. 1 – 37) 4. Waqas Qureshi, Alec J. Moorman, Micah J. Eimer, Mihai Gheorghiade. Chapter 7: Early Medical Management of Hospitalization for Heart Failure.In Baliga R, Givertz M, Pitt B. eds Medical Management of Heart Failure; Volume 1: Medical 2nd Edition London: Springer Science and Buisiness Media, October 2015 Abstracts: 1. Daniel K, Brosnihan K, Fray B, Stewart K, Kitzman D. Renin-Angiotensin-Aldosterone System Activation in Diastolic Heart Failure: Comparison with Systolic Heart Failure and Age-Matched Normal Subjects. Scientific Session of the American College of Cardiology 2005. 2. Lakoski S, Cushman M, Blumenthal R, Criqui M, Detrano R, Rundek T, D'Agostino R, Herrington D. Gender and C-Reactive Protein: Data from the Multi-Ethnic Study of Atherosclerosis (MESA) Cohort. 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; April Circulation Vol 11;14, P152; 2005. 3. Lakoski S, Herrington D, Siscovick D, Hulley S. C-reactive protein and incident hypertension in young adults: the CARDIA Study. AHA Scientific Sessions; Nov 2005. 4. Lakoski S, Li L, Langefeld C, Liu Y, Howard T, Zu J, Bowden D, Herrington D. Variation in innate immunity gene (IRAK1) is associated with c-reactive protein in Caucasian women in the Diabetes Heart Study (DHS). AHA Scientific Sessions; Nov Circulation 2005; 112 (Suppl II):II-785; 2005. 5. Lakoski SG. The Association Between Inflammation and Hypertension. Cardiovascular Epidemiology, Biostatistics and Behavioral Medicine Trainee Session : 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; April 2005. 6. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB, Jr., Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2005;46(10):1869-74. 7. Mellen P, Herrington D. Diabetes, but not the Metabolic Syndrome, Predicts Coronary Atherosclerotic Progression in Postmenopausal Women: the ERA Study. AHA 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; April Washington, D.C.: Circulation;111(14):e205; 2005. 8. Mellen P, Herrington D. Insulin Resistance and Atherosclerotic Progression: the ERA Study. AHA 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; April 2005; Washington, D.C.: Circulation ;111(14):e205; 2005. 9. Mellen P, Herrington D. Post-Challenge Glucose – How Low Should You Go?: High-Normal Two-Hour Glucose Predicts Coronary Disease Progression in Postmenopausal Women. . AHA Scientific Sessions; Nov Dallas, TX: Circulation;112(17):II-820; 2005. 10. Daniel K, Johnston, Bertoni A, Ding J, Budoff M, Bluemke D, Carr J. Using Non-Contrast Enhanced Computed Tomography to Measure Ventricular Size: Comparison of Methods. 46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention conference March 2006. 11. Daniel K, Kutcher M, Applegate R, Herrington D. Clinical and Angiographic Risk Factors for Mechanical Obstruction and No Reflow Following Percutaneous Coronary Intervention. AHA Scientific Sessions; Oct 31: Circulation,114(18); 2006. 12. Daniel K, Parks J, Schreiner P, Tsai M, Post W, Palmas W, Herrington D. Polymorphisms in ABCA1 are Associated with Serum Levels of IL-6 and CRP. 46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention March 2006. 13. Lakoski S, Brosnihan K, Herrington D. Interleukin-10Concentration and Coronary Heart Disease (CHD) Event Risk in the Estrogen Replacement and Atherosclerosis (ERA) Study: American Heart Association Scientific Sessions. AHA Scientific Sessions; Oct 31,2006.: Circulation. Vol 114(18); ; 2006. 14. Mellen P, Herrington D. Nutrient Intake and Urinary Albumin Excretion in Nondiabetics: the National Health and Nutrition Examination Survey, 2001-2002. . AHA 46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention: Circulation;113:e373. ; 2006. 15. Yeboah J, Burke G, Sutton-Tyrrell K, Mcburnie M, Crouse J, Herrington D. Association Between Endothelial Function and Cardiovascular Disease status in Older Adults: The Cardiovascular Health Study. Circulation 2006; 114(II)2006. 16. Yeboah J, Crouse J, Burke G, Hsu F, Herrington D. Flow-Mediated Dilation of Brachial Artery Predicts Incident Cardiovascular Events In Older Adults (Cardiovascular Health Study). . AHA Scientific Session Nov Circulation; Vol 114,(18); 2006. 17. Yeboah J, Crouse J, Burke G, Hsu F, Herrington D. Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in Older Adults (The Cardiovascular Health Study). Circulation 2006; 20062006. 18. Yeboah J, Crouse J, Sane D, Herrington D, Lohman K. Plasma Platelet Derived Growth Factor-BB Levels in Diabetics with Cardiovascular Events (DHS). 66th Annual American Diabetic Association Scientific Session June 2006. 19. Yeboah J, Crouse J, Sane D, Lohman K, Herrington D. Plasma platelet derived growth factor-BB levels in diabetics with cardiovascular events. J Diab 2006; 20062006. 20. Yeboah J, Sane D, Herrington D, Crouse J. P176 Plasma Platelet Derived Growth Factor-bb Levels in Diabetics with Negligible Coronary Artery Calcium Scores (Diabetes Heart Study). 7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, ; April 2006. 21. John JM. The Determinants of Exercise Tolerance in Diastolic Heart Failure Patients. Ohio Chapter of the American College of Cardiology 2007. 22. Lakoski S, Cushman M, Siscovick D, Blumenthal R, Burke G, Palmas W, Herrington D. The relationship between inflammation, obesity, and risk for hypertension in the multi-ethnic study of atherosclerosis (MESA). Finalist: poster competition. AHA Scientific Sessions 2007. 23. Lehtinen A, Newton-Cheh C, Ziegler J, Langefeld C, Freedman B, Daniel K, Herrington D, Bowden D. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. AHA Scientific Sessions Nov 2007. 24. Nelson M, Daniel K, Carr J, Freedman B, Prineas R, Bowden D, Herrington D. Associations between electrocardiographic interval durations and coronary calcium scores: The Diabetes Heart Study. AHA-Epidemiology Council Meeting; March 2007. 25. Putney D, Matura L, Daniel K, Thohan V. Negative impact of nesiritide in combination with inotropic therapy among patients admitted with acute heart failure.: JACC; 49(9 supplement 1);1022-66-76A; 2007. 26. Reeves-Daniel A, Daniel K, Alcorn S, Farney A, Rogers J, Westcott C, Assimos D, Stratta R, Adams P, Hartmann E. Impact of ethnicity on living kidney donation.: Am. J. Transplantation 2007;7(supplement 2):218; 2007. 27. Sturek J, Hedrick C, Mauldin J, Huang C, Carr J, Swords-Jenny N, Goodarzi M, Taylor K, Rotter J, Adar S, Kao W, Post W, Daniel K, Rich S. ABCG1 SNPs and variation in lipid levels in the Multi-Ethnic Study of Atherosclerosis (MESA). Clinical Cardiovascular Genomics Meeting Oct 2007. 28. Yeboah J, Burke G, Mcburnie M, Sutton-Tyrrell K, Crouse J, Herrington D. Association of Endothelial Function and Cardiovascular Disease Status in an Elderly Cohort: The Cardiovascular Health Study. AHA Annual Conference on Cardiovasular Disease Epidemiology and Prevention in Association w/the Council on Nutrition, Physical Activity and Metabolism; Feb 2007. 29. Daniel K, Hedrick C, Rich S, Allison M, Post W, Tsai M, Palmas W, McClelland R, O’Leary D, Herrington D. Cholesterol ester transfer protein (CETP) polymorphisms are associated with lipoproteins and subclinical atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). American Heart Association - Epidemiology Council Conference March 2008. 30. Duprez D, Jacobs D, Lutsey P, Herrington D, Prime D, Ouyang P, Barr G, Bluemke D. Relationship Between Endothelial, Inflammatory, Thrombotic Markers and Large and Small Artery Elasticity – Results of the Multi-Ethnic Study of Atherosclerosis (MESA) Cohort Study. ACC 57th Annual Scientific Session March JACC:51;A300-3001; 2008. 31. Duprez D, Jacobs D, Lutsey P, Herrington D, Prime D, Ouyang P, Barr G, Bluemke D. Relationship Between Endothelial, Inflammatory, Thrombotic Markers and Large and Small Artery Elasticity – Results of the Multi-Ethnic Study of Atherosclerosis (MESA) Cohort Study. NHLBI Cardiovascular Epidemiology, Biostatistics and Behavioral Medicine Trainee Session in conjunction with the 48th Cardiovascular Disease Epidemiology and Prevention Conference, and Nutrition, Physical Activity and Metabolism Conference 2008. 32. Hall W, Scheunemann L, Truitt S, Shah S, Polisner D, Rivera M, Parker L, Carson S. The Prevalence of Clinically Relevant Incidental Findings on Chest CT Angiograms Ordered to Diagnose Pulmonary Embolism. American Thoracic Society (ATS) National Conference 2008. 33. Hussein A, Imran N, John J, Durham S, Kanjwal Y. Post Coronary Artery Bypass Graft Surgery Left Ventricular Dysfunction and Prophylactic Implantable Cardiac Defibrillators: Do Patients Fall ThroughThe Cracks? . Heart Rhythm Society's 29th Annual Scientific Sessions 2008. 34. Jain M, Matulevicius S, Leonard D, Shah M, Peshock R. Prediction of Left Ventricular Peak Filling Rate by Three Short Axis Cardiac Magnetic Resonance Imaging Slices. . Society of Cardiovascular Magnetic Resonance 2008. 35. McKimmie R, Daniel K, Carr J, Bowden D, Freedman B, Register T, Hsu F-C, Lohman K, Weinberg R, Wagenknecht L. Hepatic Steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. American Heart Association - Epidemiology Council Conference March 2008. 36. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: A meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 2008;18(4):283-90. 37. Prime D, Brumback L, Arnett D, Heckbert S, Duprez D, Jacobs D, Herrington D, Bluemke D, Lima J. Relationship between increased pulse pressure measured by radial arterial tonometry or by brachial cuff, and increased left ventricular mass (LVM): The Multi Ethnic Study of Atherosclerosis (MESA). NHLBI Cardiovascular Epidemiology, Biostatistics and Behavioral Medicine Trainee Session in conjunction with the 48th Cardiovascular Disease Epidemiology and Prevention Conference, and Nutrition, Physical Activity and Metabolism Conference March 2008. 38. Reeves-Daniel A, Daniel K, Assimos D, Westcott C, Rogers J, Farney A, Stratta R, Hartmann E, Adams P, Bleyer A, Freedman B. Similar short-term outcomes among African Americans and Caucasians following live kidney donation.: Am. J. Transplantation 2008;8(supplement 2):191; 2008. 39. Shah S, Herrington D, Howard T, Burke G, Hong W, Kao L, Guo S, Siscovick D, Chakravarti A, Lima J, Psary G, Tomaselli G, Rich S, Bowden D, Post W, editors. Associations Between Genetic Variations in NOS1AP and QT Interval Duration in Four Racial/Ethnic Groups in the Multi-Ethnic Study of Atherosclerosis (MESA). American Heart Association; 2008: Circulation.118:S_884. 40. Shah S, Lehtinen A, Nelson M, Freedman B, Bowden D, Daniel K, Herrington D. Relationship Between Genetic Variants in Myocardial Sodium and Potassium Channel Genes and QT Duration in Diabetics: The Diabetes Heart Study. Poster presentation. 48th Cardiovascular Disease Epidemiology and Prevention Conference, and Nutrition, Physical Activity and Metabolism Conference; March 2008. 41. Stacey R, Bertoni A, Eng J, Bluemke D, Hundley WG, Herrington D. Modification of the Effect of Glycemic Status on Aortic Distensibility by Age in the Multi-Ethnic Study of Atherosclerosis. AHA Scientific Session 2008. 42. Stacey R, Daniel K, Bertoni A, Carr J, Freedman B, Bowden D, Herrington D. Relationships between Cardiovascular Risk Factors and Biventricular Volume in the Diabetes Heart Study. American Heart Association - Epidemiology Council Conference March 2008. 43. Truitt S, Hall W, Rivera M, Scheunemann L, Shah S, Polisner D, Parker L, Carson S. Incidental Pulmonary Nodules Found on CT Angiograms: Characteristics and Recommended Follow Up. ATS National Conference 2008. 44. Yeboah J, Johnson C, Burke G, Polak J, Post W, Lima J, Folsom A, Crouse J, Herrington D. Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in Population Based Adults: The Multi-Ethnic Study of Atherosclerosis. Accepted for presentation as a finalist for 2008 Elizabeth Barrett-Connor Research Award for Young Investigators in Training. Finalist for 2008 Elizabeth Barrett-Connor Research Award for Young Investigators in Training AHA-Epidemiology Council Conference 2008. 45. Yeboah J, Polak J, Burke G, Crouse C, Bluemke D, Lima J, Herrington D. Endothelial Dysfunction is Associated with Left Ventricular Mass and Left Ventricular Ejection Fraction (assessed using MRI) Independent of Blood Pressure and Antihypertensive Medication Use (MESA). . Circulation 2008; 118:S1096 2008. 46. Lambert N, Sacrinty M, Ketch T, Turner S, Santos R, Daniel K, Applegate R, Kutcher M, Sane D. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. American College of Cardiology Annual Scientific Session 2009. 47. Mellen PB, Goff DC. Low Prevalence of Lipid Targets Met Among US Adults With Cardiometabolic Risk: NHANES 2005-6. Circulation. 2009;120(18):S496-S. 48. Agarwal S, Houston D, Tooze J, Bauer D, Cauley J, Harris T, Koster A, Womack C, Kritchevsky S. Association between 25-hydroxyvitamin D levels and Metabolic Syndrome in Older Adults. Health Aging and Body Composition Study. AHA Scientific Sessions; November 2010; Chicago, IL2010. 49. Agarwal S, Houston DK, Tooze JA, Bauer DC, Cauley JA, Harris TB, Koster A, Womack C, Kritchevsky SB. Abstract 13226: Association between 25-hydroxyvitamin D levels and Metabolic Syndrome in Older Adults. Circulation. 2010;122(21_MeetingAbstracts):A13226-. 50. Agarwal S, Jacobs D, Vaidya D, Sibley C, Jorgensen N, Rotter J, Chen I, Herrington D. Metabolic Syndrome and Principal Component Analysis: Multi-Ethnic Study of Atherosclerosis (MESA). American Heart Association Scientific Sessions; Chicago2010. 51. Agarwal S, Morgan T, Herrington D, Xu J, Freedman B, Carr J, Bowden D. Risk stratification in a Diabetic Population with Metabolic Syndrome using Coronary Calcium Scores: Diabetes Heart Study. AHA Scientific Sessions; November, 2010; Chicago, IL2010. 52. Agarwal S, Morgan T, Herrington D, Xu J, Freedman BI, Carr JJ, Bowden DW. Abstract 9342: Risk Stratification in a Diabetic Population With Metabolic Syndrome Using Coronary Calcium Scores: Diabetes Heart Study. Circulation. 2010;122(21_MeetingAbstracts):A9342-. 53. Agarwal S, Rotter J, Vaidya D, Jorgensen N, Jacobs D, Sibley C, Chen Y-DI, Herrington D. Abstract 9113: Metabolic Syndrome and Principal Component Analysis: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2010;122(21_MeetingAbstracts):A9113-. 54. Agarwal S, Thohan V, Shlipak M, Lima J, Bluemke D, Siscovick D, Gomes A, Herrington D. Association between Cystatin C and Left Ventricular Structure and Function in the Multi Ethnic Study of Atherosclerosis. AHA Scientific Sessions; November 2010; Chicago, IL2010. 55. Agarwal S, Thohan V, Shlipak MG, Lima JA, Bluemke DA, Siscovick D, Gomes AS, Herrington DM. Abstract 8784: Association between Cystatin C and Left Ventricular Structure and Function in the Multi Ethnic Study of Atherosclerosis. Circulation. 2010;122(21_MeetingAbstracts):A8784-. 56. Ahmed FS, Jiang X-C, Hoffman EA, Yeboah J, Burkart KM, Shea S, Barr RG. Plasma Sphingomyelin And Progression Of Subclinical Pulmonary Emphysema In A Population Based Cohort. The MESA Lung Study. Am J Respir Crit Care Med. 2010;181(1_MeetingAbstracts):A3134-. 57. Allen S, Cushman M, Sane D, Johnson C, Herrington D. The Association of COX-2 Inhibitors and Non-selective Nonsteroidal Anti-Inflammatory Medications with D-dimer in the Multi-Ethnic Study of Atherosclerosis (MESA). ACC Scientific Session; March 2010. 58. Anderson J, Nettleton J, Herrington D, Johnson C, Tsai M, Siscovick D. Relationship of Dietary Fish Intake with Brachial Artery Flow-Mediated Dilation in the Multi-Ethnic Study of Atherosclerosis (MESA). . 50th Cardiovascular Disease Epidemiology and Prevention - and - Nutrition, Physical Activity and Metabolism Conference, NHLBI Trainee Session on Epidemiology; March 2010. 59. Anderson J, Nettleton J, Hundley G, al. e. Associations of plasma phospholipid omega-3 and omega-6 fatty acids and magnetic resonance imaging measures of cardiovascular structure and function: the Multi-Ethnic Study of Atherosclerosis (MESA). AHA Scientific Sessions; November 14, 2010; Chicago, IL2010. 60. Anderson JS, Nettleton JA, Hundley G, Tsai MY, Steffen L, Lemaitre RN, Siscovick D, Lima J, Prince MA, Herrington DM. Abstract 10882: The Associations of Plasma Phospholipid Omega-6 and Omega-3 Fatty Acid Levels and Cardiac Magnetic Resonance Imaging Measures of Left Ventricular Structure and Function: The Multi-Ethnic Study of Atherosclerosis. Circulation. 2010;122(21_MeetingAbstracts):A10882-. 61. Jain M, Ding J, Allison M, Criqui M, Carr J, Herrington D. Association of Visceral Adipose Tissue with Pulse Pressure in the Multi Ethnic Study of Atherosclerosis Pressure (MESA). 50th Cardiovascular Disease Epidemiology and Prevention - and - Nutrition, Physical Activity and Metabolism Conference 2010. 62. Jain M, Herrington D, Hundley WG, Bluemke D, Bertoni A. Association of Physical Activity with Pulse Pressure in the Multi-Ethnic Study of Atherosclerosis (MESA). 50th Cardiovascular Disease Epidemiology and Prevention - and - Nutrition, Physical Activity and Metabolism Conference 2010. 63. Lakoski S. Adiposity, Inflammation, and Risk of Death in Black and White Men and Women in the US: REGARDS. AHA Scientific Sessions; 2010. 64. Lakoski S. Clinical Determinants of CardiorespiratoryFitness: The Cooper Center Longitudinal Study. AHA Scientific Sessions; 2010. 65. Lakoski S. Predictors of Abdominal Aortic Calcium Incidence: The Multi-Ethnic Study of Atherosclerosis. AHA Scientific Sessions; 2010. 66. Shah S, Chan C, Tandri H, Brown E, Herrington D, Liu K, Shah SJ. Short-Term Heart Rate Variability: An Independent Predictor of Incident Heart Failure in the Multi-Ethnic Study of Atherosclerosis (MESA). 50th Cardiovascular Disease Epidemiology and Prevention - and Nutrition, Physical Activity and Metabolism Conference March 2010. 67. Shah S, Herrington D, Howard T, Divers J, Arnett D, Burke G, Kao W, Guo X, Siscovick D, Chakravarti A, Lima J, Psaty B, Tomaselli G, Rich S, Bowden D, Post W. Use of Principal Component Analysis Enhances the Ability to Study Associations Between Single Nucleotide Polymorphisms in NOS1AP and QT Interval in the Multi-Ethnic Study of Atherosclerosis (MESA). 50th Cardiovascular Disease Epidemiology and Prevention - and - Nutrition, Physical Activity and Metabolism Conference; March 2010. 68. Twomley K, D'Agostino R, Lawrence J, Melin S, Ellis L, Stacey R, Hamilton C, Torti F, Little W, Hundley WG. Early and persistent evidence of subclinical cardiovascular injury after receipt of anthracycline chemotherapy. Circulation122(21 Suppl):A12766 2010. 69. Yeboah J. Cardiovascular Risk Reclassification Using IMT or Brachial FMD. AHA Scientific Sessions Chicago, IL2010. 70. Yeboah J, Herrington D, Bertoni A, Post W, Burke G. Pre-Diabetes and the Risk of Incident Diabetes Mellitus and Cardiovascular Events in an Adult Population. (MESA). . Circulation 2010; 122(suppl #): A93892010. 71. Agarwal S, Bertoni A, Szklo M, Vaidya D, Post W, Budoff M, Rotter J, Sibley C, Herrington D. The Prevalence of Metabolic Syndrome and its Components and Incident Cardiovascular Events: Multi Ethnic Study of Atherosclerosis. Nutrition, Physical Activity and Metabolism and Cardiovascular Disease Epidemiology and Prevention Scientific Session 2011. 72. Agarwal S, Cox A, Herrington D, Morgan T, Xu J, Freedman B, Carr J, Bowden D. Vascular calcification and prediction of all cause mortality in diabetes: Diabetes Heart Study. American Heart Association Scientific Sessions 2011. 73. Agarwal S, Cox A, Herrington D, Xu J, Freedman B, Morgan T, Carr J, Bowden D. Coronary Artery Calcium Score and Prediction of Cardiovascular Mortality in Diabetes. Diabetes Heart Study. 71st American Diabetes Association Scientific Sessions 2011. 74. Agarwal S, Cox A, Herrington D, Xu J, Freedman B, Morgan T, Carr J, Bowden D. Coronary Artery Calcium and Prediction of Cardiovascular Mortality in Diabetes: Diabetes Heart Study. 23rd Annual Conference of the Michigan Chapter ACC 2011. 75. Agarwal S, Cox A, Jorgensen N, Herrington D, Xu J, Freedman B, Carr J, Bowden D. Coronary Arery Calcium Predicts Cardiovascular Mortality in Diabetes: Diabetes Heart Study. American Diabetes Association Scientific Sessions; June, 2011; San Diego2011. 76. Agarwal S, Herrington D, Cox A, Morgan T, Xu J, Carr J, Freedman B, Bowden D. The Association of Vascular Calcification and All Cause Mortality in Diabetes: Diabetes Heart Study. AHA Scientific Sessions Circulation. 2011;124:A8165; 2011. 77. Agarwal S, Jacobs D, Vaidya D, Sibley C, Jorgensen N, Rotter J, Chen I, Eng J, Herrington D. Metabolic Syndrome Derived from Principal Component Analysis and Incident Diabetes: Multi-Ethnic Study of Atherosclerosis. Nutrition, Physical Activity and Metabolism and Cardiovascular Disease Epidemiology and Prevention Scientific Session 2011. 78. Balfour P, Bertoni A, Watson K, Choi E, Lima JA, Herrington D. The Association between Amino Terminal Pro-Brain Natriuretic Peptide and Incident Heart Failure in Diabetes- The Multi Ethnic Study of Atherosclerosis. AHA Scientific Sessions2011. 79. Jain M, Allem J, Wannenburt T, Henderson R, Rubery B, Upadhya B, Simmons T. Do ICD implants for primary prevention (PP) meet Center of Medicare Services (CMS) guidelines?: The Wake Forest Baptist Medical Center experience. AHA Scientific Sessions 2011. 80. Lakoski S. Mid-Life Cardiorespiratory Fitness and 30-Year Outcomes:The Cooper Reunion Study. AHA EPI/NPAM National Conference 2011. 81. Sellers M, Liu Y, Burke G, Divers J, Ouyang P, Palmas W, Post W, Lohman K, Herrington D. Replication of the Association of PSRC1 and MTHFD1L with Coronary Artery Disease: the Multi-Ethnic Study of Atherosclerosis. AHA Scientific Sessions2011. 82. Shah SA, Chan C, Kambur T, Tandri H, Brown E, Herrington D, Liu K, Shah SJ. Short-Term Heart Rate Variability (HRV): An Independent Predictor of Incident Heart Failure (HF) in the Multi-Ethnic Study of Atherosclerosis. Wake Forest University Resident Research Day 2011. 83. Stacey R, Kock N, D’Agostino R, Torti F, Eckman D, Sane D, Workman S, Lane K, Hundley W. Doxorubicin Associated Changes in Coronary Artery Histology. J Am Coll Cardiol April 2011;57(Suppl A):A1042011. 84. Yeboah J, Redline S, Johnson C, Tracy R, Ouyang P, Blumenthal R, Burke G, Herrington D. Association between Sleep Apnea, Snoring, Incident Cardiovascular Events and All-Cause Mortality in an Adult Population. MESA. Circulation 124:A141582011. 85. Agarwal S, Cox A, Herrington D, Jorgensen N, Xu J, Carr J, Freedman B, Bowden D. Calcified atherosclerotic plaque and prediction of all cause mortality in diabetes: Diabetes Heart Study. AHA Epidemiology Scientific Sessions 2012. 86. Agarwal S, Cox A, Herrington D, Jorgensen N, Xu J, Carr J, Freedman B, Bowden D. Coronary calcium, CRP and CVD and all-cause mortality in diabetes: Diabetes Heart Study. AHA Epidemiology Scientific Sessions 2012. 87. Agarwal S, Nettleton J, De Boer I, Ix J, Siscovick D, Bild D, Burke G, Herrington D. The association of calcium supplements and incident cardiovascular events: Multi-Ethnic Study of Atherosclerosis (MESA). AHA Scientific Sessions Oral Presentation 2012. 88. Azeem A, Yeboah J, Soliman EZ, Cox A, Bertoni A, Herrington D, Bowden D. Heart Rate Corrected QT Interval is an Independent Predictor of All-Cause Mortality in a Diabetic Population – The Diabetes Heart Study. Circulation 2012;126(21 Suppl):A15550 2012. 89. Balfour P. MESA Study: NT-proBNP is a Predictor of Incident HF in Diabetes Mellitus. CardioSource World News [serial on the Internet]. 2012: Available from: youtube.cswnews.org. 90. Balfour P, Bertoni A, Chen H, Chahal H, Lima J, Herrington D. Abstract 18867: Multiple Biomarkers Predict Risk of Incident Heart Failure in Population Free of Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis. Circulation. 2012;126: A18867. 91. Balfour P, Musani S, Bidulescu A, Washington F, Taylor H, Ramachandran V, Fox E. Abstract 033: Biomarkers Relation to Prevalent Metabolic Syndrome in African Americans: A Multimarker Approach. Circulation. 2012;125:AP033. 92. Balfour P, Musani S, Williams R, Samdarshi T, Carr J, Hundley W, Terry G, Taylor H, Ramachandran V, Fox E. Abstract 19284: Clinical Determinants of Global and Regional Left Ventricular Systolic Function by Cardiac Magnetic Resonance Imaging: The Jackson Heart Study. Circulation. 2012;126: A19284. 93. Chahal H, Bluemke D, McClelland R, Liu K, Balfour P, Herrington D, Shea S, Burke G, Post W, Shi P, Olson J, Watson K, Folsom A, Lima J. Abstract 11145: Traditional and Novel Risk Factors Can Estimate Five Year Risk of Developing Heart Failure: Results from the Multi-Ethnic Study of Atherosclerosis. Circulation. 2012;126: A11145. 94. Dawood F. Correlation of the level of hs-CRP in atrial fibrillation patients in the REGARDS cohort who suffered ischemic stroke. AHA Scientific Sessions; 20132012. 95. Dawood F, Judd S, Howard V, Limdi N, Meschia J, Cushman M, Howard G, Herrington D, Soliman EZ. High Sensitivity C-reactive Protein and the Risk of Stroke in Atrial Fibrillation: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. AHA Scientific Sessions 2012. 96. Haag J, Morgan T, Robinson K, Stacey R, Thohan V, Vasu S, Hamilton C, Hundley G. Stress MRI are not Associated with Future Cardiovascular Events in High Risk Patients with Diabetes, Hypertension, or Pre-Existing Coronary Artery Disease. AHA Scientific Sessions 2012. 97. Jain M, Shah M, Rubery B, Henderson R, Simmons T, editors. Does Physician Review Improve the Accuracy of NCDR ICD Data Registry?: The Wake Forest Baptist Health Experience. Oral Presentation at 17th World Congress on Heart Disease 2012. 98. Kawel N, Nacif M, Arai A, Gomes A, Hundley W, Johnson C, Prince M, Stacey R, Lima J, Bluemke D. Trabeculated (non-compacted) and Compact Myocardium in Adults: the Multi-Ethnic Study of Atherosclerosis. Journal of Cardiovascular Magnetic Resonance 2012;14(Suppl 1):O86 (1 February 2012). 99. Owen A, Samsky M, Patel C, Hernandez A, Jentzer J, Schulte P, Felker GM, Rosenberg PB, Milano CA, Rogers JG. Outcomes in Extended-Criteria Caradiac Transplantation: A 10-Year Experience. Circulation 2012; 126(A19469): AHA Scientific Session - Oral Presentation 2012. 100. Riley R, Newby K, Don C, Alexander K, Peterson E, Peng A, Gandhi S, Kutcher M, Amsterdam E, Herrington D. Guideline-Based Treatment of Anemic STEMI Patients: A Report from the ACTION Registry® - GWTGTM. ACC Scientific Sessions 2012. 101. Riley R, Newby K, Don C, Alexander K, Peterson E, Peng A, Gandhi S, Kutcher M, Amsterdam E, Herrington D. Guideline-Based Treatment of Anemic STEMI Patients: A Report from the ACTION Registry® - GWTGTM. Resident and Fellow Research Day, Wake Forest School of Medicine 2012. 102. Riley R, Newby K, Don C, Roe M, Holmes D, Gandhi S, Kutcher M, Herrington D. Timing of Electrocardiographic Diagnosis in STEMI Patients with an Initial NonDiagnostic ECG: A Report from the AHA Mission: Lifeline Program. ACC Scientific Session 2012. 103. Riley R, Newby K, Don C, Roe M, Holmes D, Gandhi S, Kutcher M, Herrington D. Timing of Electrocardiographic Diagnosis in STEMI Patients with an Initial Non-Diagnostic ECG: A Report from the AHA Mission: Lifeline Program. Resident and Fellow Research Day, Wake Forest School of Medicine 2012. 104. Riley R, Newby L, Don C, Alexander K, Peterson E, Peng S, Gandhi S, Kutcher M, Amsterdam E, Herrington D. How Treatment of Anemic STEMI Patients Impacts Outcomes. Resident and Fellow Research Day; 2012; Wake Forest School of Medicine2012. 105. Sellers M, Herrington D, Liu Y, Howard T, Hixson J, Shimmin L. Epigenetic Analysis of Lipid Phenotypes in Liver Tissue from the Pathological Determinants of Atherosclerosis in Youth (PDAY) Study. AHA Scientific Session 2012. 106. Smith C, Yeboah J, Sims M, Harman J, Terry J, Crump M, Doherty M, Carr J, Taylor H, Jr. Association of Coronary Calcium Score with Cardiovascular Risk Factors in African Americans: The Jackson Heart Study (JHS). Circulation 125: AP1542012. 107. Stacey R, Andersen M, Hundley G, Thohan V. Comparison of Systolic and Diastolic Criteria for Isolated Left Ventricular Noncompaction in Cardiac MRI. Journal of Cardiovascular Magnetic Resonance. 2012;14(Suppl 1):P148 (1 February 2012). 108. Yeboah J, Carr J, Terry G, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff M, editors. Computer Tomography derived cardiovascular risk markers, incident cardiovascular events and all- cause mortality in adults free of clinical cardiovascular disease. The Multi Ethnic Study of Atherosclerosis. Circulation 2012;126: A9536; 2012. 109. Yeboah J, Smith CL, Sims M, Fox E, Ge Y, Terry G, Taylor H, Carr J. Coronary Artery Calcium Score Improves the Net Reclassification Index of Prevalent Cardiovascular Disease in African Americans: The Jackson Heart Study. Circulation: AP159 2012. 110. Agarwal S, Cox A, Herrington D, Morgan T, Xu J, Carr J, Freedman B, Bowden D. Vascular calcification and prediction of cardiovascular mortality in diabetes: diabetes heart study. ADA Scientific Sessions 2012. Poster Presentation. 111. Agarwal S, Cox A, Herrington D, Morgan T, Xu J, Carr J, Freedman B, Bowden D. Vascular calcification and prediction of cardiovascular mortality in diabetes: diabetes heart study. 24th Annual Conference of the Michigan Chapter ACC 2012. Poster Presentation. 112. Al-Mallah M, Jurashek S, Whelton S, Ahong Y, Blumenthal R, Nasir K, Schairer J, Alam M, Quershi W, Blaha M, Keteyian S. Does Cardiorespiratory Fitness Have the Same Prognostic Value in Men and Women? Data From the FIT Project. . American Heart Association Scientific Sessions 2013. 113. Al-Mallah M, Rubin J, Keteyian S, Alam M, Qureshi W, Schairer J, Nasir K, Blaha M. Racial Differences in the Prognostic Value of Exercise Capacity: An Analysis of 52,515 Consecutive Patients From the FIT Project. . American Heart Association Scientific Sessions 2013. 114. Azeem A, Yeboah J, Bertoni A, Burke G, Turkbey E, Szklo M, Herrington D, editors. Association of Hemoglobin A1C with Cardiovascular Disease and All-Cause Mortality in Individuals without Diabetes – The Multi-Ethnic Study of Atherosclerosis. Circulation 2013;127(12Suppl): AP278; 2013. 115. Azeem A, Yeboah J, Soliman E, Cox A, Bertoni A, Herrington D, Bowden D. Heart Rate Corrected QTc Interval is an Independent Predictor of Mortality in a Diabetic Population – The Diabetes Heart Study. American Heart Association Scientific Session; November 2012; Los Angeles Convention Center, Los Angeles, CA2013. 116. Cammarata M, Howard T, Register T, Shea S, Hawkins G, Burke G, Jacobs D, Hoeschele I, Liu Y, Herrington D. Association of DNA Methylation and Gene Expression of the P2Y12 Receptor: The Multi-Ethnic Study on Atherosclerosis. AHA Scientific Sessions November 2013. 117. Gibson A, Yeboah J, Arnan M, Sacco R, Balaha M, Szklo M, Herrington D. Coronary Artery Calcium Score is an Independent Predisctor of Incident Stroke in Population Based Adults. MESA. Circulation 2013; 128:A161752013. 118. Hall M, Brinkley T, Morgan T, Hamilton C, Jordan J, Stacey R, Chughtai H, Soots S, Little W, Hundley W. Ectopic fat is associated with gender-specific reducations in left bentricular myocardial perfusion index during dobutamine stress. AHA Scientific Sessions November 2013. 119. Khouri Y, Muthukumar L, Katukuri N, Shaik I, Agarwal S, Mangalpally K, Jahania S, Hammond R, Bandopadhyay, Precevski, Mattei J, Spears J. Intra-aortic Aqueous Oxygen Infusion in a Swine Model of Acute Isovolumic Anemia. 2013: Circulation. 2013; 128; A16; 2013. 120. Lakoski S. Cardiorespiratory fitness and risk of cancer incidence and cause-specific mortality following a cancer diagnosis in men: The Cooper Center longitudinal study. American Society of Clinical Oncology (ASCO) National Meeting 2013. 121. Lakoski S. Peak Factor Xa Generation As A Candidate Biomarker For Bevacizumab-Induced Thrombotic and Bleeding Events. Internal Society of Thrombosis and Haemostasis 2013. 122. Lakoski S. Predictors of Factor Xa Generation in Breast Cancer. International Society of Thrombosis and Haemostasis 2013. 123. Lakoski S. Cardiac Rehabilitation as a Platform to Provide Oncology Rehabilitation. AHA Scientific Sessions 2013. 124. Lakoski S. Meeting PA Guidelines and Risk of CVD and Cancer Mortality. AHA Scientific Sessions 2013. 125. Mahler S, Riley R, Burke G, Hiestand B, Miller C. Real-time use of a chest pain risk stratification clinical decision rule: a cautionary tale. American College of Emergency Physician’s Annual Scientific Assembly; 20132013. 126. Owen A. Coronary Artery Calcium Score is an Independent Predictor of Incident Stroe in Poplation Based Adults. Multi-Ethnic Study of Atherosclerosis (MESA). AHA Scientific Sessions; November 20132013. 127. Soliman E, Safford M, Muntner P, Khodneva Y, Judd S, Dawood F, Thacker E, Neil Z, Howard V, Howard G, Herrington D, Cushman M. Atrial Fibrillation is a Risk Factor for Incident Myocardial Infarction. American College of Cardiology 62nd Annual Scientific Session 2013. 128. Vasu D, Lovato J, Terry J, Taylor H, Fox E, Yeboah J, Correa A, Hundley W, Carr J. Association of Obesity with Aortic Stiffness in African-American Men and Women: The Jackson Heart Study. ACC Scientific Sessions2013. 129. Vasu S, Lovato J, Terry J, Taylor H, Fox E, Correa A, Yeboah J, Hundley W, Carr J. Obesity Increases Aortic Stiffness in African-Americans: The Jackson Heart Study. Journal of American Cardiology 2013: 61(10_S); 2013. 130. Virgadamo S, Azeem A, Yeboah J, Rodriguez C, Cox A, Bowden D, Herrington D, editors. Premature Ventricular Complexes Predict Mortality in a Population with Type 2 Diabetes – The Diabetes Heart Study. Circulation 2013;127(12 Suppl):AP049; 2013. 131. Virgadamo S, Azeem A, Yeboah J, Rodriguez C, Cox A, Bowden D, Herrington D. Premature Ventricular Complexes Predict Mortality in a Population with Type 2 Diabetes – The Diabetes Heart Study. Seventh Annual Residents and Fellow Research Day, Department of Internal Medicine; May 7, 2013; Wake Forest School of Medicine2013. 132. Virgadamo S, Azeem A, Yeboah J, Rodriguez C, Cox A, Bowden D, Herrington D. Premature Ventricular Complexes Predict Mortality in a Population with Type 2 Diabetes – The Diabetes Heart Study. ACP North Carolina Chapter Sessions; February 2013; Durham, NC2013. 133. Yeboah J, Teixido G, Jacobs D, Terry J, Lima J, Ge Y, Lovato J, Goff D, Carr J. Comparison of Aortic Root Dimensions Using Multi Slice Computer Tomography and 2D Echocardiography. CARDIA. Circulation 2013: 128:A99372013. 134. Yeboah J, Terry J, Lovato J, Jacobs D, Ge Y, Sidney S, Lloyd-Jones D, Carr J. Increased Cardiovascular Risk is Associated with Outward Remodeling of theThoracic Aorta. Circulation 2013; 128:A102742013. 135. Anderson J, Sacrinty M, Turner S, Gandhi S, Santos R, Kutcher M, Little W, Applegate R, editors. Gender Differences in Vascular Complications Associated with Transradial Cardiac Catheterization and Percutaneous Coronary Intervention: A Single-Center Experience. ACC Scientific Session; 2013 136. Aggarwal S, Bluemke D, Hundley G, Lima J, Mittleman M, Ouyang P, Parikh N, Vaidya D, Yeboah J, Herrington D. Abstract 33: Parity is Associated with Aortic Remodeling: The Multi-Ethnic Study of Atherosclerosis (MESA). Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism Scientific Sessions Circulation. 2014;129:A33; 2014. 137. Aggarwal S, Herrington D, Viadutiu C, Swett C, Rodriguez C. Abstract 17937: Higher Parity is Associated with Left Ventricular Diastolic Dysfunction: Echo Study Of Latinos (Echo SOL). AHA Scientific Sessions; Chicago IL, Nov Circulation. 2014;130:A17937; 2014. 138. Al-Mallah M, Blaha M, Quershi W, Brawner C, Keteyian S, editors. Fitness and Incident Diabetes: An Analysis of 55,897 Patients from The FIT Project. American College of Cardiology; 2014. 139. Al-Mallah M, Qureshi W, Pantelic M, Nour K, editors. Long Term Prognostic Value of Coronary CT Angiography in Suspected Coronary Artery Disease, A 62 Months Median Follow-Up Study. American College of Cardiology 2014. 140. Alvarez L, Stacey RB, Byrum G, Hundley G, Upadhya B, editors. Utility of Late Gadolinium Enhancement Cardiac Magnetic Resonance in Troponin Postiive Chest Pain and Unobstructed Coronary Arteries. Wake Forest School of Medicine Eighth Annual Research Day Poster Presentation, May 2014. 141. Alvarez L, Stacey RB, Byrum G, Hundley G, Upadhya B. Utility of Late Gadolinium Enhancement Cardiac Magnetic Resonance in Troponin Postiive Chest Pain and Unobstructed Coronary Arteries. SCMR Scientific Sessions; New Orleans, LA 2014. 142. Azeem A, Campbell W, Rivard A, Mcmullan M. Congenital Absence of Left Pericardium: Case Report. UMMC Congenital Heart Disease Symposium; April 12, 2014; Jackson Medical Mall, Jackson, MS2014. 143. Balfour P, Musani S, Williams R, Samdarshi T, Carr J, Hundley F, Terry G, Taylor H, Vasan R, Fox E, editors. Clinical Determinants of Global Left Ventricular Systolic Function by Cardiac Magnetic Resonance Imaging: The Jackson Heart Study. Wake Forest School of Medicine Eighth Annual Research Day Poster Presentation, May 2014. 144. Balfour PC, Jr., Rodriguez CJ, Ferdinand KC. Blood pressure and cardiovascular effects of new and emerging antidiabetic agents. Current hypertension reports. 2014;16(8):455. 145. Carr J, Terry J, Yeboah J, Ge Y, Lovato J, Polonsky T, Reis J, Goff D, Liu K, Jacobs D. Coronary Artery Remodeling and Subclinical Atherosclerosis: the CARDIA study. Circulation 2014; 129:AP3212014. 146. Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF, Lundgren JD, Neaton JD, Soliman EZ. Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study. Journal of electrocardiology. 2014;47(2):264-71. PMCID: Pmc3951578. 147. Gabriel E, Shaya GE, Nasir K, Blumenthal R, Keteyian SJ, Brawner C, Quershi W, Al-Mallah M, Blaha M, editors. High cardiorespiratory fitness attenuates risk of short – term mortality after first myocardial infarction: The Henry Ford FIT project. American Heart Association Scientific Sessions 2014; Chicago, IL Nov 16 – 19, 2014. 148. Gomadam P, Stacey RB, Johnsen A, Kitzman D, Kon N, Upadhya B, editors. Cardiac Papillary Fibroelastoma as a Source of Stroke: A Case Study. Wake Forest School of Medicine Eighth Annual Research Day Poster Presentation, May 2014. 149. Hassan M, Qureshi W, Sroujieh LS, Albashaireh D, BouMalham S, Liroff M, Amjad W, Khalid F, Hadid H, Alirhayim Z. Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2014;15(3):278-85. 150. Howard TD, Mathias RA, Seeds MC, Herrington DM, Hixson JE, Shimmin LC, Hawkins GA, Sellers M, Ainsworth HC, Sergeant S, Miller LR, Chilton FH. DNA methylation in an enhancer region of the FADS cluster is associated with FADS activity in human liver. PloS one. 2014;9(5):e97510. PMCID: Pmc4026313. 151. Lakoski S. Racial Differences in CVD Mortality Among Women wth Ductal Carcinoma in Situ of the Breast. AHA Scientific Sessions; 2014. 152. Leigh A, Qureshi W, Swett K, Dharod A, Allison M, Cai J, Gonzalez F, Hurwitz B, Shah S, Desai A, Spevack D, Rodriguez C. Comparison of Reference Vaulues for Cardiac Structure in Hispanics with the American Society of Echocardiography Reference Ranges: The Echocardiographic Study of Latinos (ECHO-SOL). Wake Forest School of Medicine Eighth Annual Research Day Poster Presentation, May 2014. 153. Mahler S, Riley R, Hiestand B, Russell G, Hoekstra J, Lefebvre C, Nicks B, Cline D, Askew K, Elliott S, Herrington D, Burke G, Miller C. The HEART Pathway Randomized Trial: Identifying Emergency Department Patients with Acute Chest Pain for Early Discharge. AHA Scientific Sessions 20142014. 154. Milks M, Upadhya B, Hundley G, Stacey R, editors. Right Ventricular Stress-Induced Perfusion Defects and Late Gadolinium Enhancement in Coronary Artery Disease. Wake Forest School of Medicine Eighth Annual Research Day Poster Presentation, May 2014. 155. Milks M, Upadhya B, Hundley G, Stacey R. Right Ventricular Stress-Induced Perfusion Defects and Late Gadolinium Enhancement in Coronary Artery Disease. SCMR Scientific Sessions; New Orleans, LA 2014. 156. Quershi W, Blaha M, Brawner C, Keteyian S, Al-Mallah M. Inverse Relationship Between Inflammation and Cardiorespiratory Fitness: The Henry Ford Hospital ExercIse Testing Project (FIT Project). American Heart Association Scientific Chicago, IL Nov 2014. 157. Quershi W, Blaha M, Brawner C, Keteyian S, Al-Mallah M. Cardiorespiratory Fitness is Associated with Decreased Risk of Incident Atrial Fibrillation: An Alayisis of 66,479 Patients from The Henry Ford Hospital Exercise Testing (FIT) Project. American Heart Association Scientific Sessions2014. 158. Quershi W, Nasir U, Ali Z, Qadir S, Hayat-Syed M, Alqalyoobi S, Mawri S, Al-Mallah M. Continuous Positive Airway Pressure Therapy as a Therapy for Cardiac Arrhythmias: Meta - Analysis of 14 Studies. American Heart Association Scientific Sessions Chicago, IL Nov 2014. 159. Qureshi W, Wagenknecht L, Watkins S, Chilton F, Rotter J, Carlos L, Herrington D. Metabolomic Features Associated with Incident Hypertension – Results from Insulin Resistance Atherosclerosis Study. AHA Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism Scientific Sessions March 18-21, 2014; San Francisco, CA2014. 160. Qureshi W, Yeboah J, Bertoni A, Burke G, Herrington D, Redline S. Risk of Incident Hypertension and Diabetes Mellitus in Habitual Snorers and Sleep Apneic Individuals. MESA. Circulation 2014; 129:AP1022014. 161. Qureshi W, Shah AJ, Salahuddin T, Soliman EZ. Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey). The American journal of cardiology. 2014;114(1):59-64. PMCID: Pmc4334655. 162. Qureshi W, Soliman E, Solomon S, Arking D, Shah A, Shah D, Alonso A, Wagenknecht L, Herrington D. Traditional Risk Factors for Atrial Fibrillation in Individuals with Normal Left Atrial Size: The Atherosclerosis Risk in Communities Study. Presentation Abstract. AHA Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism Scientific Sessions 2014. 163. Sander S, Pace A, Azeem A, Campbell W. Recurrent Discrete Aortic Stenosis and its Hemodynamic Consequences. Congenital Heart Disease Symposium; April 12, 2014; Jackson Medical Mall, Jackson, MS2014. 164. Stacey R, Leaverton P, Schocken D, Bertoni A. Association of Unrecognized Myocardial Infarctions With Impaired Fasting Glucose in the Multi-Ethnic Study of Atherosclerosis. American Heart Association Scientific Sessions; November, 2014; Chicago, Illinois 2014. 165. Stacey R, Meng M, Upadhya B, Rodriguez C, Zhao D, Pu M. Prognosis of Un-Operated Aortic Stenosis: Risk Stratification by Doppler Echocardiography. American Society of Echocadiography; Portland, OR 2014. 166. Stacey R, Meng M, Upadhya B, Rodriguez C, Zhao D, Pu M. Effect of Aortic Valve Surgery on Different Types of Severe Aortic Stenosis Classified by Echocardiography. American Society of Echocadiography; Portland, OR 2014. 167. Stacey R, Upadhya B, Milks M, Deutsch C, Lin T, Hundley W, Thohan V. Reconciling Systolic and Diastolic Measures of Left Ventricular Noncompaction Cardiomyopathy in Cardiac Magnetic Resonance. American Heart Association Scientific Sessions; November, 2014; Chicago, Illinois 2014. 168. Yeboah J. Which Subclinical Measures Improve Risk Prediction Session: Cardiovascular Risk Prediction 2014: Beyond Risk Scores. AHA Scientific Sessions Chicago, IL2014. 169. Ahmad A, Qureshi W, Brawner C, Keteyian S, Ehrman J, Blumenthal R, Nasir K, Blaha M, Al-Mallah M. Prognostic value of cardiorespiratory fitness in patients with chronic renal dysfunction: The FIT (Henry Ford Exercise Testing) Project at American Heart Association Scientific Sessions. American Heart Association Scientific Sessions; November 6-11, 2015; Orlando, FL2015. 170. Al Rifai M, Blankstein R, Martin S, McEvoy J, Blaha M, Blumenthal R, Ouyang P, Nasir K, Yeboah J, Shea S, Polak J, Miedema M. The Prevalence and Correlates of Advanced Atherosclerosis among Those with Optimal Low-Density Lipoprotein Cholesterol Levels: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2015; 131:AP1762015. 171. Al-Mallah M, Ahmed A, Quershi W. The Frequency and Predictors of Referral to Coronary Angiography Among Patients with Moderate or Severe Ischemia on Stress Testing American College of Cardiology 64th Annual Scientific Session and TCT@ACC-i2; San Diego, CA. 2015. 172. Alqalyoobi M, Nasir UB, Mawri S, Sabbagh S, Quershi W, editors. Continuous Positive Airway Pressure as a Therapy of Atrial Fibrillation in Obstructive Sleep Apnea. . American Heart Association Quality Control and Outcomes Research 2015; Baltimore, MD 173. Balfour P, Gonzalez J, Shaw P, Perez M, Izarnotegui V, Sobzack M, Watson D, Beller G, Bourque J. High Frequency QRS Analysis has Incremental Diagnostic Accuracy Over ST-Segment Analysis Alone for the Detection of Myocardial Ischemia. Mid-Atlantic Capital Cardiology Symposium of the American College of Cardiology; November 21, 2015; Washington, DC2015. 174. Byrum G, III, Caine A, Jr , Franzil J, Upadhya B, Hundley W, Stacey R. Cardiac-Cycle Related Changes in Trabeculated Left Ventricular Volume in Cardiac Magnetic Resonance Imaging. American College of Cardiology Scientific Sessions; March, 2015; San Diego, CA 2015. 175. Byrum G, III, Caine A, Jr, Franzil J, Upadyha B, Hundley W, Stacey R. Cardiac-Cycle Related Changes in Trabeculated Left Ventricular Volume in Cardiac Magnetic Resonance Imaging. Internal Medicine Research Day May, 2015; Wake Forest University School of Medicine2015. 176. Caine A, Jr, Franzil J, Milks M, Upadhya B, Hundley W, Stacey R. Racial Differences in Left Ventricular Trabeculations by Cardiac Magnetic Resonance Imaging. Internal Medicine Research Day; May, 2015; Wake Forest University School of Medicine 2015. 177. Caine A, Jr, Franzil J, Milks M, Upadhya B, Hundley W, Stacey R. Racial Differences in Left Ventricular Trabeculations by Cardiac Magnetic Resonance Imaging. American College of Cardiology Scientific Sessions March, 2015; San Diego, CA 2015. 178. Cammarata M, Kincaid E, Santos R, Gnadhi S, Douglas C, Hermann D, Zhao D. Transcaval Approach to Thoracic Endovascular Aortic Repair. TCT Conference2015--Challenging Case Presentation2015. 179. Cheng J, Vasu S, Cheng P, Upadhya B, Stacey R, Pu M. Do Real-Time 3-D Transesophageal Echocardiographic Images Actually Reflect What We Directly Visualize? American Society of Echocardiography Scientific Sessions June, 2015; Boston, MA2015. 180. Ehrman J, Brawner C, Al-Mallah M, Qureshi W, Schairer J, Blaha M, Keteyian S. Change in cardiorespiratory fitness in inversely related to mortality among black and white patients: Data from Henry Ford Exercise Testing (FIT) project American Heart Association Scientific Sessions; ; Orlando, FL2015. 181. Flueckiger P, Qureshi W, Blaha M, Burke G, Sandfort V, Michos E, Herrington D, Yeboah J. Class I Indications for Stain Therapy in Primary Prevention by Three Cholesterol Guidelines and Risk of Incident Cardiovascular Outcomes: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2015;132:A124902015. 182. Gilbert O, Hermann D, Alvarez L, Deutsch C, Aldrich A, Sacrinty M, ., Pu M, Stacey R, Applegate R, Gandhi S, Zhao D. Transcatheter Aortic Valve Replacement Customization Based on Paravalvular Aortic Regurgitation Location. American College of Cardiology Scientific Sessions March, 2015; San Diego, CA 2015. 183. Gilbert O, Riley R, Newman J, Haley W, Morisk D, Goff D. The Association Between Self-Reported Medication Adherence Scores and Systolic Blood Pressure Control: A SPRINT Baseline Data Study. American Society of Hypertension Scientific Sessions 20152015. 184. Gonzalez J, Auger-Cornejo D, Chen X, Yang Y, Balfour P, Shaw P, Salerno M, Kramer C, Epstein F, Bilchick K. CURE-SVD DENSE by Cardiac Magnetic Resonance (CMR) versus Speckle-Tracking Echocardiography (STE) a predictor of Cardiac Resynchronization Therapy (CRT) response in patients with Advanced Heart Failure. Mid-Atlantic Capital Cardiology Symposium of the American College of Cardiology; November 21, 2015; Washington, DC2015. 185. Gonzalez J, Lamie C, Shaw P, Balfour P, Yang Y, Kramer C, Salerno M, Hagspiel K, Norton P. Quality Improvement Project to Reduce Radiation Exposure and Contrast Use in Patients Undergoing Pre-Transcatheter Aortic Valve Replacement (TAVR) Evaluation by Computed Tomography (CT). Mid-Atlantic Capital Cardiology Symposium of the American College of Cardiology; Washington, DC2015. 186. Gonzalez J, Shaw P, Balfour P, Flournoy C, Missel J, Hazarika S, Yang Y, Norton P, Hagspiel K, Kramer C, Shah N, Salerno M. Cardiac CTA to Improve Cardiac Risk Stratification for Pre-Liver Transplantation. Mid-Atlantic Capital Cardiology Symposium of the American College of Cardiology; November 21, 2015; Washington, DC2015. 187. Lakoski S. Racial Differences in 20-Year Cardiovascular Outcomes Among Childhood and Young Adult Cancer Survivors ASCO National Meeting 2015. 188. Mohammed A, Quershi W, Soliman E. Electrocardiographic versus Echocardiographic Left Ventricular Hypertrophy in Prediction of Congestive Heart Failure in the Elderly American Heart Association EPI/Lifestyle Scientific Sessions Baltimore, MD 2015. 189. Ohyama Y, Ambale-Venkatesh B, Noda C, Tura G, Chugh A, Liu C, Redheuil A, Stacey R, Dietz H, Gomes A, Prince M, Evangelista A, Wu C, Hundley G, Bluemke D, Lima J. Longitudinal Change in Aortic Stiffness Measured by Cardiac MRI in Middle-Aged and Older Adults: The Multi-Ethnic Study of Atherosclerosis. American College of Cardiology Scientific Sessions April, 2015; San Diego, CA2015. 190. Olson NC, Cushman M, Judd SE, McClure LA, Lakoski SG, Folsom AR, Safford MM, Zakai NA. American Heart Association's Life's Simple 7 and Risk of Venous Thromboembolism: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. J Am Heart Assoc. 2015;4(3). 191. O'Neal W, Efird J, Qureshi W, Yeboah J, Alonso A, Heckbert S, Nazarian S, Soliman E. Computed Tomography (CT): Coronary Artery III Abstract 18434: Coronary Artery Calcium Progression and Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2015;132:A184342015. 192. O'Neal W, Lakoski S, Qureshi W, Judd S, Howard G, Howard V, Cushman M, Soliman E. The Association between Cancer and Atrial Fibrillation: The REasons for Geographic And Racial Differences in Stroke Study American Heart Association EPI/Lifestyle Scientific Sessions Baltimore, MD 2015. 193. O'Neal W, Qureshi W, Nazarian S, Kawel-Boehm N, Blumke D, Lima J, Soliman E. Electrocardiographic intrinsicoid deflection and incident congestive heart failure: The Multi-ethnic study of atherosclerosis (MESA) American Heart Association Scientific Sessions; ; Orlando, FL2015. 194. Pandey A, Parashar A, Kumbhani DJ, Agarwal S, Garg J, Kitzman D, Levine BD, Drazner M, Berry JD. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circulation Heart failure. 2015;8(1):33-40. 195. Quershi W, Balaha M, Keteyian S, Brawner C, Al-Mallah M. No Racial Differences in the Association of Cardiorespiratory Fitness with Incident Atrial Fibrillation: Results from The Henry Ford ExercIse Testing Project (The FIT Project). American College of Cardiology 64th Annual Scientific Session and TCT@ACC-i2; San Diego, CA2015. 196. Qureshi W, Wagenknecht L, Watkins S, Chilton F, Rotter J, Carlos L, Herrington D. Metabolomic Features Associated With Incident Hypertension - Results From Insulin Resistance Atherosclerosis Study American Heart Association Scientific Sessions; ; Orlando, FL2015. 197. Qureshi W, Flueckiger P, Blaha M, Michos E, Sandfort V, Herrington D, Burke G, Yeboah J. The Impact of Replacing the Pooled Cohort Equation with Other CVD Risk Scores on Atherosclerosis Cardiovascular Disease Risk Assesment: MESA. Circulation 2015;132:A101282015. 198. Qureshi W, Kaplan R, Sweet K, Burke G, Davilgus M, Jung M, Talavera G, Chrinos D, Reina S, Rodriguez C. ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latino Based on Findings From the HCHS-SOL American Heart Association Scientific Sessions; ; Orlando, FL2015. 199. Qureshi W, Nasir U, Soliman E, Belford P, Gandhi S, Applegate R, Zhao D. Risk of Post Procedural Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valvular Replacement - A Meta-analysis. American Heart Association Scientific Sessions; November 6-11, 2015; Orlando, FL2015. 200. Qureshi W, O'Neal W, Al-Mallah M. Digoxin Use in Atrial Fibrillation Is Associated with Increased Risk of Mortality: A Systematic Review and Meta-Analysis of More than 200,000 Patients American College of Cardiology 64th Annual Scientific Session and TCT@ACC-i2; San Diego, CA2015. 201. Qureshi W, O'Neal W, Brawner C, Ehrman J, Keteyian S, Blaha M, Al-Mallah M. The Interaction Between the Prognostic Value of Chronotropic Incompetence and Cardiorespiratory Fitness: The Henry Ford Exercise Testing (FIT) Project. American Heart Association Scientific Sessions; November 6-11, 2015; Orlando, FL2015. 202. Qureshi W, O'Neal W, Yulia K, Judd S, Safford M, Muntner P, Howard V, Howard G, Soliman E. Between Opioid Use and Atrial Fibrillation: the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study American Heart Association EPI/Lifestyle Scientific Sessions Baltimore, MD 2015. 203. Sharma R, Yeboah J, Stacey R. Ascending Aortic Index and Risk of Cardiovascular Disease and Mortality in the Multi-Ethnic Study of Atherosclerosis. Internal Medicine Research Awards Day; May, 2015; Wake Forest School of Medicine 2015. 204. Sharma R, Yeboah J, Stacey R. Ascending aortic index and risk of cardiovascular events and mortality in the Multi Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2015; 65(10_S)2015. 205. Stacey R, Leaverton P, Schocken D, Peregoy J, Lyles M, Bertoni A, Burke G. Impaired Fasting Glucose Increases Risk for an Unrecognized Myocardial Infarction: The Cardiovascular Health Study. AHA Scientific Sessions November 2015; Orlando, FL2015. 206. Yeboah J, Qureshi W, Rodriguez C, Liu S, Carr J, Lima J, Hundley G, Herrington D. Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population Based Adult Cohort. Circulation 2015;132A99982015. 207. Brawner C, Al-Mallah M, Qureshi W, Ehrman J, Schairer J, Blaha M, Keteyian S. Change in Cardiorespiratory Fitness is Inversely Related to Mortality Among Men and Women: Data From the Henry Ford Exercise Testing (FIT) Project American Heart Association Scientific Sessions Orlando, FL2015 208. Almahmoud MF, Herrington D, Lima J, Jordan J, Liu CY, Michos ED, Venkatesh B, Kestenbaum B, Katz R. Fibroblast Growth Factor-23 and cardiac MRI indices of Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis. ACC2016. 209. Anouti K, Qureshi W, Refaat M. Postoperative Atrial Fibrillation and Stroke Following Left Atrial Appendage Closure During Routine Cardiac Surgery. Annual Meeting of the American College of Cardiology Chicago, IL2016. 210. Azeem A. Relation of Left Ventricular Structure to Incident Heart Failure in African Americans: The Jackson Cohort of the Atherosclerosis Risk in Communities Study. AHA EPI; 2016. 211. Azeem A, Alexander M, Majithia V, Hall M. Is it Libman-Sacks Endocarditis? American College of Cardiology Scientific Sessions 2016. 212. Azeem A, Musani S, Beard W, Butler K, Mosley T, Fox E. Long Term Prediction of Incident Heart Failure in African-Americans-The Atherosclerosis Risk in Communities Study. AHA EPI 2016. 213. Gonzalez J, Li Y, Shaw P, Balfour P, Yang Y, Kay J, DiMaria J, Weltman A, Salerno M, Meyer C, Epstein F, Kramer C. Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD. 19th Annual Scientific Sessions, Society for Cardiovascular Magnetic Resonance; January 27-30, 2016; Los Angeles, CA2016. 214. Leigh A, Kaplan R, Swett K, Balfour P, Kansal M, Talavera G, Perreria K, Blaha J, Benjamin E, Robertson R, Bhartnagar A, Rodriguez C, editors. Association of The Intensity and Duration of Cigerette Smoking Exposure with Cardiac Structure and Function in Current Daily Smoker: The Echocardiogram Study of Hispanic/Latinos(ECHO-SOL). American College of Cardiology; 2016; Chicago, IL. 215. Leigh A, Soliman E, O"Neal W. Electrocardiographic Versus Echocardiographic Left Ventricular Hypertrophy as a Predictor of CV Disease Events in the General Population. AHA 2016 EPI Scientific Sessions 2016. 216. Majeed M, Oseni A, Akanbi O, Agboto V, Okafor H. Prognostic Significance of Left Ventricular Hypertrophy (LVH) by Electrocardiography in a Minority-Predominant Heart Failure (HF) Cohort. AHA QCOR Scientific Meeting 2016. 217. Oseni AQ, WT, Almahmoud M, Bertoni A, Blumke D, Hundley W, Lima J, Herrington D, Soliman E. Left Ventricular Hyperthrophy by Electrocardiogram Versus Cardiac Magnetic Resonance Imaging as a Predictor for Heart Failure: The MESA Study. AHA EPI/Lifestyle Scientific Meeting 2016. 218. Qureshi W, Ahmed A, Khalid F, Al-Mallah M. Vitamin D Levels Are Associated With Prevalence and Burden of Perfusion Defects on Myocardial Perfusion Imaging Annual Meeting of American College of Cardiology; ; Chicago,IL2016. 219. Shaw P, Yang Y, Chow K, Gonzalez J, Balfour P, Meyer C, Epstein F, Bourque J, Salerno M, Kramer C. Quantitative CMR perfusion imaging identifies reduced flow reserve in microvascular coronary artery diease. 19th Annual Scientific Sessions, Society for Cardiovascular Magnetic Resonance; January 27-30, 2016; Los Angeles, CA2016. Electronic Publications: Sidharth A. Shah, M.D., M.S. Wake Forest Baptist First Hospital in North Carolina to Implant Newly Approved Device to Treat Heart Failure http://www.wakehealth.edu/News-Releases/2011/Wake_Forest_Baptist_First_Hospital_in_North_Caro lina_to_Implant_Newly_Approved_Device_to_Treat_Heart_Failure.htm Herrington DM, Lakoski S. Chest Pain in Postmenopausal Woman on Hormone Therapy. Cardiosource Web Site, American College of Cardiology Foundation and Elsevier, Inc. February 2004. Yeboah J. Cardiovascular Risk Prediction: Two More Studies, Little Progress. Forbes.com, LLC; 2012 [updated 2012; cited August 21, 2012] http://www.forbes.com/sites/larryhusten/2012/08/21/cardiovascular-risk-prediction-two-more-studies-li ttle-progress/ Yeboah J.. 2 Tests May Improve Heart Patients' Care, Studies Suggest. US News and World Report, LP; 2012 [updated 2012; cited August 21, 2012] http://health.usnews.com/health-news/news/articles/2012/08/21/2-tests-may-improve-heart-patients-car e-studies-suggest Yeboah J. Which Heart Risk Test Rates Best? : WebMD, LLC; 2012 [updated 2012; cited August 21, 2012]; http://www.webmd.com/heart/news/20120821/which-heart-risk-test-rated-best Yeboah J. Predicting Heart Attack Risk: A Calcium Test May Help. Time, Inc.; 2012 [updated 2012; cited August 22, 2012] http://healthland.time.com/2012/08/22/predicting-heart-attack-risk-a-calcium-test-may-help/ INVITED COMMENTARY: Mellen PB, Herrington DM. Estradiol shows no overall effect on blood pressure. First to Know: The North American Menopause Society. 2005 Dec 15; www.menopause.org/news.html INVITED PRESENTATIONS: Dr. Susan Lakoski “Women and Cardiovascular Disease” Wake Forest University School of Medicine Medical Student Class. August 2003. Dr. Susan Lakoski “The Association Between Inflammation and Hypertension.” Wake Forest University School of Medicine Cardiology Research Conference, June 2004 Dr. Phillip Mellen “Cardiovascular Disease and Women” Cardiovascular pathophysiology lecture series for 2nd year medical students, Wake Forest University, August 2004 Dr. Susan Lakoski “Gender Differences and C-Reactive Protein.” Wake Forest University School of Medicine Cardiology Research Conference, January 2005 Dr. Susan Lakoski “The Association Between Inflammation and Hypertension.” Cardiovascular Epidemiology, Biostatistics and Behavioral Medicine Trainee Session, April 2005 Dr. Phillip Mellen “The Metabolic Syndrome, Insulin Resistance, and Coronary Atherosclerotic Progression” Cardiology Research Conference, Wake Forest University, June 2005 Dr. Phillip Mellen “New Pharmacogenetic Data in Hypertension” Satellite Symposium Invited Lecture, 14th Annual Scientific Meeting, Quebec Society of Hypertension, Montreal, Quebec, Canada, January 14, 2006 (sponsored by Bristol-Meyers Squibb Canada and Sanofi-Aventis) Dr. Phillip Mellen “Whole Grains and Heart Disease” Cardiology Research Conference, Wake Forest University, May 2006 Dr. Kurt Daniel “Predictors of Poor Epicardial Blood Flow Following PCI” Cardiology Research Conference, Wake Forest University, May 2006. Dr. Susan Lakoski “Cardiovascular Risk Assessment in Women” Medicine Cardiology Research Conference, June 2006. Dr. Jerry John “Response to Postural Change in Diastolic Heart Failure: Decreased Left Ventricular Compliance Contributes To Reductions in Stroke Volume and Cardiac Output” Medicine Cardiology Research Conference, June 2006. Dr. Susan Lakoski Invited Speaker, AHA Special Session: Improving Cardiovascular Risk Assessment in Women. “Framingham Risk Score Low Balls Risk in Women.” Nov 2006 Dr. Jerry John “Exercise Intolerance in Diastolic Heart Failure – Evaluation using Cardiopulmonary Exercise Testing and Echocardiography”, Cardiology Research Conference, Jan 2007. Dr. Joseph Yeboah “Relationship between Carotid IMT and Brachial Flow-Mediated Dilation in an Elderly Cohort”, Cardiology Research Conference, Jan 2007. Dr. Stewart Allen “The association of COX-2 Inhibitors with Endothelial Function”, Cardiology Research Conference, Jan 2007. Dr. Darryl Prime “Clinical Utility Of Measures Calculated From The Radial Artery Pulse Pressure Wave Form” Cardiology Research Conference, Feb 2007. Dr. Susan Lakoski “Cardiovascular Disease Risk in Women” Wake Forest University School of Medicine Medical Student Class, Feb 2007. Dr. Susan Lakoski “Cardiovascular Disease Risk in Women” Winston-Salem Community, June 2007. Dr. Susan Lakoski Invited Speaker, Cardiovascular Seminar: Novel Risk Factors for Hypertension. “Inflammation, Blood Pressure, and Risk for Hypertension.” Nov 2007. Dr. Brandon Stacey “Aortic Stiffness and the Left Ventricle” Cardiology Research Conference, Jan 2008. Dr. Sidharth Shah “ The Identification and Pathophysiologic Implication of ANG-(1-2) in Human Cardiovascular Disease States” Cardiology Research Conference, Jan 2008. Dr. Sidharth Shah”EP Review: Wolff-Parkinson-White (WPW)”. Wake Forest University School of Medicine Cardiology Fellows’ Conference- October 2008. Dr. Sidharth Shah “Cardiac Arrest Syndrome”. Wake Forest University School of Medicine Cardiology Fellows’ Conference-December 2008. Dr. Manish Jain “Aortic Stiffness: Is it associated with visceral fat and physical activity?” Cardiology Research Conference, Jan 2009. Dr. Darryl Prime “The Association between Nitrate Therapy during Acute Myocardial Infarction and Mortality” Cardiology Research Conference Jan 2009. Dr. Kurt Daniel “Heart Size by Cardiac CT – A new Epidemiologic (and Clinical?) Tool” Cardiology Research Conference March 2009. Dr. Stewart Allen “Propensity Score Analysis of Indices of Thrombosis in Users of Selective and Non-selective NSAIDs” Cardiology Research Conference March 2009. Dr. Matthew Belford “Flow Medicated Dilation and Endothelial Derived Proteins” Cardiology Research Conference May 2009. Dr. Sidharth Shah “Associations between NOS1AP Genetic Variants and the QT Interval”, Cardiology Research Conference June 2009. Dr. Brandon Stacey “Modification of the Effect of Glycemic Status on Aortic Distensibility by Age”, Cardiology Research Conference June 2009. Dr. Sidharth Shah “Mitral Stenosis”. Wake Forest University School of Medicine Cardiology Fellows’ Conference- February 2009. Dr. Sidharth Shah “Percutaneous Aortic Valve Replacement”. Wake Forest University School of Medicine Cardiology Fellows’ Conference- April 2009. Dr. Sidharth Shah Alcohol Septal Ablation”. Wake Forest University School of Medicine Cardiology Fellows’ Conference-July 2009. Dr. Sidharth Shah “Current Concepts in Atrial Fibrillation”. Wake Forest University School of Medicine Cardiology Fellows’ Conference-August 2009. Dr. Subhashish Agarwal “Metabolic Syndrome & Ethnic Differences: Need for a New Definition”. Wake Forest University School of Medicine Cardiology Fellows’ Conference-January 2010. Dr. Jennifer Anderson “Omega-3 Fatty Acid/Fish Intake and Brachial Artery Flow-Mediated Dilation in the Multi-Ethnic Study of Atherosclerosis”. Wake Forest University School of Medicine Cardiology Fellows’ Conference-January 2010. Dr. Kurt Daniel “Routine Immediate PCI after Lyutics: A Systemic Review and Meta-Analysis”. Wake Forest University School of Medicine Cardiology Fellows’ Conference-January 2010. Dr. Jennifer Anderson “Fighting Heart Disease with Food”. Wake Forest University Health Sciences BestHealth – March 2010. Dr. Darryl Prime “Relation of Periprocedural Elevated White Blood Cell Count to Stent Thrombosis after Percutaneous Coronary Intervention for Acute Myocardial Infarction" Wake Forest University School of Medicine Cardiology Fellows’ Conference-March 2010. Dr. Brandon Stacey “Glucose, Insulin, and Vascular Stiffness” Wake Forest University School of Medicine Cardiology Fellows’ Conference-March 2010. Dr. Pelbreton Balfour “Amino-Terminal pro-BNP, Type 2 Diabetes Mellitus and Incident Heart Failure” Wake Forest University School of Medicine Cardiology Fellows’ Conference-January 2011. Dr. Matthew Sellers “Epigenetic and Cardiovascular Disease” Wake Forest University School of Medicine Cardiology Fellows’ Conference- January 2011. Dr. Manish Jain “Guidelines based ICD Implantation for Primary Prevention of Sudden Cardiac Death: WFUBMC Experience” Wake Forest University School of Medicine Cardiology Fellows’ Conference – March 2011. Dr. Brandon Stacey “Noncompaction of the left ventricle: Cardiac MRI from WFUBMC-Design and Initial Analysis” – Wake Forest University School of Medicine Cardiology Fellows’ March 2011. Dr. Mattnew Belford “Flow Mediated Dilation and Endothelial Derived Proteins” Wake Forest University School of Medicine Cardiology Fellows’ Conference – April 2011. Dr. Sidharth Shah “Short-term Heart Rate Variability (HRV): A potential Predictor of Incident Heart Failure in MESA” - Wake Forest University School of Medicine Cardiology Fellows’ – Conference - April 2011. Dr. Jennifer Anderson “Sex differences in the relationship of dietary polyunsaturated fatty acids and cardiovascular disease” - Wake Forest University School of Medicine Cardiology Fellows’ – Conference - May 2011. Dr. Amir Azeem “Hemoglobin A1c and Cardiovascular Risk” - - Wake Forest University School of Medicine Cardiology Fellows’ – Conference -January 2012. Dr. Robert Riley “Investigating Guideline-Based Care of STEMI Patients. Two Analyses from the NCDR ACTION Registry-GWTG” - Wake Forest University School of Medicine Cardiology Fellows’ – Conference - February 2012.. Dr. Stewart Allen “Everolimus-eluting stents: The Wake Forest Experience” Cardiology Research Conference February 2012. Dr. Sidharth Shah “Genetic Variants in NOS1AP and the QT Interval Across Race/Ethnicty in Adults Without Cardiovascular Disease” Cardiology Research Conference March 2012. Dr. Matthew Belford “Flow Mediated Dilation and Endothelial Derived Proteins” Cardiology Research Conference March 2012. Dr. Jennifer Anderson “Dietary Long-Chain n-3 Polyunsaturated Fatty Acids and Incident Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA)” Cardiology Research Conference April 2012. Dr. Manish Jain “Does Physician Review Improve the Accuracy of National Cardiovascular Data Registry (NCDR) ICD Registry Data Submission?” Cardiology Research Conference May 2012. Dr. Matthew Sellers “Genetics and Cardiovascular Disease” Cardiology Research Conference June 2012. Dr. Michael Cammarata “Genetic and Epigentic Determinates of Platelet Reactivity” Cardiology Research Conference January 2013. Dr. Ashleigh Owen “ Brugada Syndrome, benigh non-ischemis ST elevation, or something in between? Identification of distinct ST segmanet parameters associated with sudden cardiac death” Cardiology Research Conference January 2013. Dr. Farah Dawood “Electrocardiographic Spatial QRS-T Angle and Incident Cardiovascular Disease in HIN-Infected Patients (from the Strategies for the Management of Antiretroviral Therapy SMART Study)” Cardiology Research Conference January 2013. Dr. Robert Riley “The HEART Pathyway Trial and ASAP Cath Study” Cardiology Research Conference March 2013. Dr. Amir Azeem “Glycated Hemoglobin and Cardiovascular Risk Assessment in Individuals without Diabetes Mellitus” Cardiology Research Conference March 2013. Dr. Pelbreton Balfour “Multiple Biomarkers Predict Risk of Incident Heart Failure in Population Free of Cardiovascular Disease: MESA” Cardiology Research Conference April 2013. Dr. Pelbreton Balfour “Clinical Case Conference”, Cardiology MR Imaging Conference, May 2013. Dr. Matthew Sellers “Replication and Functional Validation of SNPs Previously Associated with Coronary Artery Disease” Cardiology Research Conference May 2013. Dr. Manish Jain “Insulation Failure in St. Jude Riata Family Leads: Wake Forest Baptist Health” Cardiology Research Conference May 2013. Dr. Jennifer Anderson “Why I Still Love Fish: A Nutrition $ Cardiovascular Disease Update for 2013” Cardiology Research Conference June 2013. Dr. Ashleigh O. Gibson “Coronary Artery Calcium Score is an Independent Predictor of Incident Stroke in Population Based Adults. Multi-Ethnic Study of Atherosclerosis (MESA)” Cardiology Research Conference January 2014. Dr. Waqas Qureshi “Metabolomics” Cardiology Research Conference January 2014. Dr. Shivani Aggarwal “Parity and Cardiovascular Disease” Cardiology Research Conference February 2014. Dr. Michael Cammarata “Epigenetic Modification and Gene Expression of P2RY12” Cardiology Research Conference February 2014. Dr. Joseph Yeboah “Risk Prediction in Primary Cardiovascular Event Prevention” Department of Internal Medicine Grand Rounds, March 13, 2014. Dr. Robert Riley “Evaluating Chest Pain in the ED: A Multidisciplinary Paradigm Shift”, Cardiology Research Conference, April 23, 2014. Dr. Matthew Belford, “Radial Artery Patency” Cardiology Research Conference Grand Rounds, May 14, 2014. Dr. Pelbreton Balfour, “Risk Prediction of Incident Heart Failure: Results from the MESA Study”, Cardiology Research Conference Grand Rounds, May 21, 2014.